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ABSTRACT
The control of mammary gland morphogenesis is very complex, 
involving autocrine, paracrine and endocrine factors. The obligate requirement 
for adipose tissue during early development has been well established but the 
reason(s) has yet to be resolved.
In the first part of our study, we investigated how this intimate 
association of the gland with adipose tissue affects development. Mammary 
cell proliferation and apoptosis were quantified in mice from weaning through 
until maturity. Cell proliferation was relatively constant in virgin mice, 
irrespective of age, whilst apoptosis was much lower in aged mice, and varied 
in a way which is deserving of further studies, as it could have significant 
implications for pathological mammary development and breast cancer. 
During pregnancy, proliferation increased from a barely-detectable level at the 
start of gestation to a maximum in mid-pregnancy. High levels were 
maintained through until day 1 of lactation and measurable proliferation 
continued throughout lactation. Apoptosis was absent until the very end of 
pregnancy, was high immediately post-partum but then decreased before 
reaching its maximum during post-lactational involution. Cell proliferation did 
not differ significantly between a first and second lactation, whereas the 
postpartum surge of apoptosis was only observed in a first lactation starting 
early in life. It was also demonstrated that lactational history affects the way in 
which the gland proliferates and undergoes apoptosis during oestrous cycles 
late in life. Proliferation was reduced by a previous lactation, but apoptosis
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was not significantly affected. This also has implications for breast cancer 
incidence.
Next, we examined the hypothesis if leptin, an endocrine product of 
adipose tissue, alters mammary development, using a combination of in vitro 
mammary culture techniques and in vivo murine models of leptin deficiency. 
Caprine and murine mammosphere cultures were used to test the effects of 
leptin of murine and ovine origin on mammary cell differentiation and the 
proliferation of ovine mammary cell culture. There was no reproducible 
evidence of a direct effect of leptin on mammary differentiation, either using 
ovine or murine leptin in both caprine and murine mammospheres. Neither did 
leptin affect mammary cell proliferation in cell culture. Nonetheless, 
wholemount analysis showed that mammary development in leptin deficient 
ob/ob mice is impaired. These mice had reduced ductal growth and increase 
size of fat pad. To determine whether leptin was directly responsible or it is 
just the failure of these mice to reach puberty, oestrogen and progesterone 
were administered as subcutaneous implants. Treatment with mammogens 
stimulated mammary cell proliferation in both wildtype and ob/ob mice. Based 
on the in vitro and in vivo studies, we can conclude that leptin per se is not 
essential for mammary development and the defect observed was an indirect 
consequence of the fact that ob/ob mice are sterile
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CHAPTER ONE
REVIEW OF THE LITERATURE
1.1 OVERVIEW
The mammary gland is of great interest to biologists from different disciplines 
due to its unique developmental features and complex regulation by hormones 
and growth factors. Besides being influenced by many systemic endocrine 
factors, interactions between the different cell types and the extracellular 
matrix also play a role in the normal development and function of the gland. 
The fat pad of the gland, which previously was thought to be an inert matrix 
that supports epithelial growth, has been shown to be an essential component 
in normal epithelial growth, possibly through paracrine signalling (Hovey et 
al.,1999). Receptors for some of the key players involved in normal 
development of the gland have also been shown to be expressed in the fat pad, 
suggesting that the actions of key hormones and growth factors might be 
mediated through cell types other than the mammary epithelial cell.
The aim of this review is to discuss the roles of hormones and growth 
factors; the contribution of the mammary environment and the possible role of 
leptin in mammary gland development and function.
1.2 MAMMARY GLAND STRUCTURE
The mammary gland is an ectodermally-derived exocrine organ located within 
the subcutaneous tissue of the anterior thoracic wall (Sakakura,1987). It is 
made up of two main cellular components namely the parenchyma and 
adipose stroma. The parenchyma refers to the system of branching ducts
l
connected to the nipple by a single primary duct. The structure of the 
mammary ducts is made up of an inner layer of mammary epithelial ductal 
cells and an outer layer of myoepithelial cells. The other cellular component, 
adipose stroma, consisting of connective tissue and adipocytes, acts as a 
substratum within which the parenchyma grows and functions. The 
parenchyma and surrounding stroma is separated by the extracellular matrix 
(ECM). The ECM consists of a highly complex mixture of molecules 
including various collagens, fibronectin, laminin and glycosaminoglycans. In 
addition to the two main cellular components, the mammary gland is also 
composed of fibroblasts, endothelial cells and lymphatic vessels.
During late pregnancy and lactation, the mammary gland consists 
mostly of lobules of alveoli (Figure 1.1), each composed of a monolayer of 
specialised epithelial cells surrounding a central lumen. Milk is secreted into 
the lumen and removed through the ductal system. In ruminants (Figure 1.2), 
the ducts empty into a large cavity, the gland cistern, and milk is removed 
through a single aperture in the teat. By contrast, in humans and rabbits 
(Figure 1.2), each of the ducts draining separate lobules terminates at the 
nipple instead of being supplied by a common sinus.
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Figure 1.1 Diagrammatic representation of a cluster of mammary alveoli 
(Mepham,1987)
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Figure 1.2 Arrangement of mammary duct systems in different species 
(Mepham,1987).
In rats (a), the ducts unite to form a single galactophore opening at the tip of 
nipple while in rabbits (b), several galactophores open at the nipple. For 
humans (c), each galactophore is dilated at the base of nipple (which is 
surrounded by a pigmented areola) to form a sinus. In cows (d), the main ducts 
open into a large gland cistern which communicates through a narrow aperture 
with the teat cistern. Milk is removed via the teat canal.
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1.3 MAMMARY GLAND DEVELOPMENT
The development of the mammary gland is unusual in that the majority of the 
process occurs in the adult organism. Developmental stages are generally 
similar in all mammals and can be divided into: embryonic, pre-pubertal, 
pubertal, pregnancy, lactation and involution.
1.3.1 Embryonic
In the embryonic stage, very little development goes on in the gland. In mice, 
the mammary rudiment is observed around days 10-11 of life (Daniel and 
Smith, 1999). These are seen as buds which appear on the mammary lines 
(bilateral, ectodermal thickenings on the ventrolateral body wall). After the 
mammary buds are fully formed, they undergo a resting phase until days 12- 
13. At this point, the surrounding mesenchyme, which has differentiated into 
mammary mesenchyme, stimulates outgrowth of the mammary bud. At days 
15-16, a mammary sprout is observed and this sprout leads to the formation of 
the small ductal tree observed towards the end of gestation. The process has 
been reviewed by (Robinson et al.,1999).
1.3.2 Pre-Pubertal and Pubertal
At birth, the mammary duct system is still rudimentary. During the first 3 
weeks of life, the mammary gland undergoes isometric growth, where the 
mammary ducts elongate and ramify at a rate not surpassing that of the animal 
(Knight and Peaker,1982). With the onset of puberty at around 4 weeks of age, 
ductal elongation and branching becomes allometric. Rapid proliferation 
occurs within the terminal end buds (TEBs), resulting in the invasion and 
filling of the fat pad by the duct system. The TEBs drive ductal morphogenesis
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in the gland by producing a supply of differentiated ductal and myoepithelial 
cells (Daniel and Silberstein,1987). Once this is achieved, mammary growth 
becomes isometric. This growth is oestrous cycle associated and has been 
demonstrated in rodents and ruminants (Sinha and Tucker, 1969; Grahame and 
Bertalanffy,1972). Sutton and Suhrbier (1967) showed highest mitotic activity 
in rats during metestrus which was consistent with Schedin et al.(2000) 
observations. However, in cows, oestrous instead was shown to have the 
highest rate of proliferation (Sinha and Tucker, 1969). This might imply a 
species-dependent estrous associated proliferation in the mammary gland. The 
overall increase in cell number during the oestrous cycle is still small despite 
this mitotic activity. With each oestrous cycle, the mammary gland increases 
the complexity of its branching network. From having primary ducts, the 
formation of lower-order ducts, through the bifurcation of the end buds, is also 
observed. Besides that, formation of secondary ducts along differentiated 
ducts and in certain species lobular-alveolar development is also detected 
(Daniel et al.,1996).
1.3.3 Pregnancy
When the animal proceeds through pregnancy, the mammary gland undergoes 
extensive and rapid proliferation resulting in an exponential growth of the 
mammary gland. In fact, the great majority of mammary growth occurs during 
gestation. In hamsters, 94% of all mammary growth takes place during 
gestation (Sinha et al.,1970) while in mice 78% was observed during this 
period (Brookreson and Turner, 1959). During this period, the lipid content of 
adipocytes in the gland stroma are displaced to allow maximal expansion of 
the mammary epithelial ductal network. Terminal end buds start forming
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lobulo-alveolar structures responsible for milk secretion during lactation. 
Whilst during earlier stages of development proliferation of the mammary 
epithelial cells was mostly observed in the terminal end buds during gestation 
ductal cells are also capable of undergoing cell division (Bresciani,1971).
Besides undergoing allometric growth, the size of mammary 
epithelial cells also increases (Foster, 1977). A possible explanation for this is 
that secretory capability is acquired as the animal gets nearer to parturition. In 
goats, there is an increase in udder volume due to an increased concentration 
of lactose, indicative of terminal differentiation, as the animal proceeds 
through pregnancy (Fleet et al.,1975). Besides observing an increase in lactose 
concentration, an increase in RNA content and the appearance of milk specific 
products were also detected (Cowie et al.,1980). In rats, casein messenger 
RNA could be detected as early as day 5 of pregnancy (Rosen et al.,1975).
1.3.4 Lactation
When lactation commences, there is a marked increase in the expression of the 
milk protein genes and the synthesis of the components of milk. After 
parturition, the secretion in the first few days is called colostrum. It differs 
from normal milk in the sense that there is a higher concentration of proteins, 
sodium, and chloride and a lower concentration of lactose and potassium. 
Besides that, colostrum also contains high amounts of immunoglobulins to 
provide immunity to the neonate. With successive milkings, the composition 
rapidly becomes that of whole milk which is attributed to the closure of tight 
junctions (Nguyen and Neville, 1998).
Milk yield is a combination of the number of secreting cells and the 
activity of the cell. During lactation, the number of secretory cells continues
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to increase in some species. In mice, an increase in cell proliferation post 
partum was observed for the first 5 days of lactation (Knight and 
Peaker,1982). In ruminants, in the case of goats (Anderson et al.,1981) a 
similar observation was observed but in sheep this was not true 
(Anderson, 1975). This increase in the number of secretory cells due to 
proliferation occurring during lactation has been correlated with the 
subsequent increase in milk yield (Knight and Wilde, 1987). Even though 
proliferation is observed during lactation, differentiation of the mammary 
epithelial cell is still more prevalent during this stage.
1.3.5 Involution
In rodents, significant changes occur in the mammary gland upon weaning. 
Secretory activities of the mammary epithelial cell decreases, the lobulo- 
alveolar structures observed during lactation collapse, the replacement of most 
of the epithelial cells with adipose tissue and extensive tissue remodelling 
occurs reverting the mammary gland to that of the mature virgin state. In the 
situation of ruminants, partial loss of the mammary cell population instead of 
extensive tissue remodelling is involved (Wilde et al.,1997). Unlike rodents, 
the involuting gland in ruminants does not regress to the virgin state, in 
addition to apoptosis occurring in some alveolar cells, the remainder of the 
cells have been shown to dedifferentiate (Wilde et al.,1997; Li et al.,1999).
The removal of secretory epithelial cells is achieved through 
apoptosis (Quarrie et al.,1996) and phagocytosis by surrounding macrophages. 
Apoptosis in the involuting gland can be divided into 2 stages namely 
proteinase-independent and proteinase-dependent pathways (Lund et al.,1996). 
The proteinase-independent pathway of apoptosis involves the expression of
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genes for p53 and interleukin-lp converting enzyme (ICE), while in the 
proteinase-dependent pathway, expression of proteinases like matrix 
metalloproteinases (MMPs) and serine proteinase urokinase-type plasminogen 
activator (uPA), responsible for the degradation of the extracellular matrix 
(ECM) through tissue-remodelling, is involved.
1.4 ENDOCRINE CONTROL OF MAMMARY DEVELOPMENT 
AND FUNCTION
Classical studies have demonstrated that growth and differentiation of the 
mammary gland is regulated by systemic hormones (Lyons, 1958; Cowie et 
al.,1965). These hormones include estrogen, progesterone, growth hormone, 
prolactin, insulin and glucocorticoids.
1.4.1 Estrogen
Estrogen is one of the essential hormones required for ductal growth during 
adolescence and lobuloalveolar growth during pregnancy. Mice lacking the 
estrogen receptor displayed a rudimentary ductal structure lacking any TEBs 
or alveolar development (Bocchinfuso and Korach,1997). In addition, when 
estrogen was administered to ovariectomised adult mice, there was an increase 
in DNA synthesis exclusively in the TEBs (Shyamala,1997). Estrogen 
receptors have been detected in the mouse mammary gland (Haslam and 
Shyamala,1981; Haslam, 1989). Whether estrogen exerts its action locally on 
the mammary gland has been debated since in vitro studies failed to reproduce 
the mitogenic effect of estrogen on mammary epithelial cells (Richards et 
al.,1988). Nonetheless, studies conducted by Silberstein et al.(1994), which 
involved local implantation of anti-estrogen pellets in the mammary gland,
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confirmed the action of estrogen was direct. However, Zeps et al.(1998) 
showed that in the proliferating mammary epithelial cells in pubertal mice, 
50% are estrogen receptor negative suggesting that estrogen’s effect might be 
mediated through paracrine signalling. This seems even more likely when both 
mammary epithelial and stromal cells express the estrogen receptor (Haslam 
and Nummy,1992). Based on all these observations, we can see that estrogen 
exerts its effect locally; whether it’s through direct effect on mammary 
epithelial cells or cell-cell interactions remains to be determined.
1.4.2 Progesterone
Progesterone like estrogen has been shown to be mitogenic in the mammary 
gland (Haslam, 1988). In vitro experiments have demonstrated that 
progesterone is capable of inducing side-branching of the ductal epithelium 
(Atwood et al.,2000) and generating multi-lobular ductal branching (Darcy et 
al.,1995). This effect of progesterone was further complemented by in vivo 
studies employing progesterone receptor (PR) null mice whereby PR-deficient 
mice exhibit impairment of pregnancy-associated phenotype (Humphreys et 
al.,1997).
Expression of the progesterone receptor is detected in virgin and 
pregnant mammary tissue but is down-regulated during lactation. In mature 
mice, the expression of the progesterone receptor is regulated by oestrogen 
(Haslam, 1988). Intriguingly, this dependence was not detected in virgin mice, 
suggesting an estrogen-independent effect of progesterone (Haslam, 1988). 
Besides regulating expression of PR, oestrogen also seems to have an additive 
effect on the actions of progesterone as when ovariectomised mice were 
treated with both oestrogen and progesterone, there was a significant increase
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in cell proliferation when compared with either steroid alone 
(Shyamala,1997). This is understandable since in the presence of estrogen, 
progesterone not only stimulated DNA synthesis in the end buds; outgrowth 
from lateral walls of the ducts and branches were also observed.
Besides acting as a mitogen, progesterone has also been shown to 
inhibit the expression of prolactin (Mizoguchi et al.,1997) and accumulation of 
casein mRNA during pregnancy (Rosen et al.,1978). Thus we can see that 
progesterone, in concert with oestrogen, acts as a mitogen responsible for the 
formation of lobulo-alveolar structures responsible for milk secretion during 
lactation and at the same time it also act as an inhibitor of lactogenesis by 
preventing the expression of the lactogenic hormone, prolactin, during 
mammogenesis.
1.4.3 Prolactin
Early studies in 1928 demonstrated that administration of pituitary extracts to 
rabbits with a well-developed lobulo-alveolar mammary system initiated 
secretion of milk (Strieker and Grueter,1928). The active molecule responsible 
was later identified to be prolactin (PRL). Prolactin is produced in the anterior 
lobe of the pituitary gland. It influences the immune system, reproduction and 
also acts as an osmoregulator (Bole-Feysot et al.,1998). In the mammary 
gland, PRL exerts its effect by binding to receptors on the mammary epithelial 
cells or even adipocytes (Ling et al.,2000). Upon binding, the receptor 
dimerizes and activates Janus kinase 2 (JAK2). JAK2 in turn activates 
transcription factors belonging to the family of signal transducers and 
activators of transcription (STAT).
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The relative importance of prolactin in mammary gland function varies 
between species. PRL is both a mitogen and a differentiation factor in the 
gland, however its mitogenic action is less well recognized. Early work by 
Lyons demonstrated that prolactin was one of the essential hormones in rats 
required to produce lobulo-alveolar growth (Lyons, 1958). This dependence on 
PRL was again shown in C3H mice (Vonderhaar,1987). Recently, using PRL- 
deficient and PRL-receptor knockout mice, it was again shown that ductal 
branching during puberty and alveolar development during pregnancy was 
reduced (Horseman et al.,1997; Ormandy et al.,1997). In vitro studies carried 
out by Darcy et al.(1995) also showed that prolactin has a role in regulating 
lobulo-alveolar growth. In contrast, the mammogenic role of prolactin was not 
observed in ruminants. When pregnant sheep or cows were treated with 
bromocriptine, which inhibits prolactin secretion, there was no effect on 
mammary development (Schams et al.,1984).
The more established role of prolactin is at the initiation of lactation. In 
ruminants, both in cows (Schams et al.,1972) and goats (Davis et al.,1983), 
when prolactin was lowered around parturition, a delay in the onset of 
secretion of milk and reduction in milk yield postpartum was observed, an 
effect which could be reversed with exogenous prolactin (Akers et al.,1981). 
In vitro studies also demonstrated that prolactin alone was capable of inducing 
casein synthesis (Devinoy et al.,1978) and a-lactalbumin (Sankaran and 
Topper, 1984) activity in rabbit explants. Whether prolactin is important for 
maintaining lactation requires more studies. In rodents, milk yield decreases 
with bromocriptine treatment (Knight et al.,1986) but in cows, there is only a 
slight correlation between serum prolactin and milk yield (Koprowski and
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Tucker, 1973). Furthermore, supplementary prolactin has no effect on bovine 
milk yield (Plaut et al.,1987). On the other hand, Knight and Wilde (1993) and 
Forsyth and Lee (1993) demonstrated that treating lactating goats with 
bromocriptine before milking led to a significant decrease in milk yield. In 
sheep treatment with bromcriptone, during established lactation, also leads to 
reduced milk yield (Kann et al., 1978).
From all the above observations, prolactin has proven to be a key 
factor, at least in some species, in mammary gland function. In ruminants, it is 
not a major player neither is its role trivial.
1.4.4 Growth Hormone
Increasing evidence suggests that growth hormone (GH) is important in 
normal mammary gland development. It has been demonstrated to be 
mitogenic in both rodents and pubertal heifers. GH stimulated end bud 
formation (Silberstein and Daniel, 1987) and lobulo-alveolar development in 
mice (Plaut et al.,1993). In pubertal heifers, there was an increase in mammary 
parenchyma and a decrease in stromal tissue when treated with GH (Sejrsen et 
al.,1986).
The role of GH during lactogenesis remains unclear. It has been 
demonstrated to be lactogenic in mice (Nandi, 1958) while in cows (Simmons 
et al.,1994), this was not the case. Nonetheless, when injected into lactating 
cows, there was a marked increase in milk production (Collier et al.,1984; 
Bauman and Eppard,1985; McCutcheon and Bauman, 1986). This increase in 
milk yield is due to GH’s effect on nutrient partitioning in the mammary gland 
(Bauman and Currie, 1980). In lactating rats, when prolactin was deficient, 
anti-GH antiserum reduced milk yield by 50%, which could be restored by
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injecting with GH (Madon et al.,1986). It should be noted that GH and 
prolactin have strong homology in their sequence and human GH is capable of 
binding to the human prolactin receptor (Kossiakoff et al.,1994; Somers et 
al.,1994). It is capable of activating transcriptional factors belonging to the 
Stat family and also inducing the binding of Stat5 to the GAS site in the 13- 
casein promoter in vitro (Smith et al.,1997).
Whether growth hormone exerts its effect locally or through systemic 
interactions remain to be elucidated. When lactating cows were treated with 
somatotropin, there was an increase in IGF-1 both in the serum and the 
parenchyma of the mammary gland (Glimm et al.,1988), suggesting that GH 
might function through IGF-1. Recently, studies have demonstrated the 
expression of growth hormone receptors in bovine (Sinowatz et al.,2000; 
Plath-Gabler et al.,2001) and mouse mammary gland (Ilkbahar et al.,1999), 
suggesting that GH might have a more direct role in mammary growth and 
function. Paradoxically, it was observed that growth hormone did not bind to 
the receptor in the bovine mammary gland (Keys and Djiane,1988). Hence to 
elucidate whether GH exerts its effect locally or systemically needs further 
investigation.
1.4.5 Insulin
Insulin has little effect on mammogenesis in vivo, but at supraphysiological 
concentration has been demonstrated to be essential in vitro (Forsyth, 1971). It 
is believed at these concentrations, insulin binds to the IGF-1 receptor (Kasuga 
et al.,1981). Tucker (2000) hypothesized that in this situation, insulin may 
substitute for growth hormone-induced secretion of IGF-1. Next, Hovey et al.
(1998) showed in the mouse mammary epithelial cell line COMMA-ID that
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treatment with insulin induced a mitogenic effect. Insulin has also been 
implicated to have a cell-survival role since it was shown that HC11 cells 
cultured only in prolactin and dexamethasone underwent apoptosis, which 
could be inhibited by the addition of insulin (Merlo et al.,1996). Besides that, 
insulin has also been shown to have a stimulatory effect in casein gene 
expression and induction of a-lactalbumin activity in mammary epithelial 
cells from mid-pregnant mice (Prosser et al.,1987).
During lactation, hypoinsulinaemia and insulin-resistance of 
adipocytes are a common feature of rats and domestic ruminants (Vernon and 
Pond, 1997). These changes both support nutrient supply to the mammary 
tissue and away from body tissue. In lactating rats, insulin treatment caused an 
increase in glucose utilization and lipid uptake in the mammary gland 
(DaCosta and Williamson, 1994). The main effect of insulin during lactation 
hence is likely to be on the partitioning of nutrients in the mammary gland.
1.4.6 Glucocorticoids
Early pituitary ablation and hormone replacement studies indicated that 
glucocorticoids are essential for the maintenance of lactation. Paterson and 
Linzell (1971) showed that at parturition there was a sharp increase in level of 
cortisol and this was accompanied by the formation of tight junctions between 
neighbouring mammary secretory cells. Hence it has been implicated in the 
regulation of lactogenesis through the induction of tight junction formation. 
Hydrocortisone was found to suppress ductal branching and induce alveolar 
morphogenesis in rat mammary organoid culture, and its removal leads to a 
loss of differentiated function in the cells (Darcy et al.,1995). Several in vitro 
studies, using transepithelial electrical resistance (TER) as a measure of tight
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junction formation, have shown in mice that when the mammary epithelial 
cells were treated with glucocorticoids, there was enhanced tight junction 
formation (Zettl et al.,1992; Stelwagen et al.,1999). Furthermore, Thompson 
(1996) also demonstrated that local injection of cortisol into late pregnant 
mammary gland of the goat produced a decrease in sodium, and an increase in 
the potassium concentration of the mammary secretion product, indicating 
tight junction closure. When plasma cortisol was elevated in lactating cows, 
the permeability of mammary tight junctions was reduced (Stelwagen et 
al.,1998). All of this evidence clearly implicate glucocorticoids as a regulator 
of tight junction formation.
In addition to its role in tight junction formation, glucocorticoids have 
also been demonstrated to have an effect on milk protein synthesis. In rabbit 
mammary gland organ culture, cortisol enhances prolactin-induced casein 
synthesis (Devinoy et al.,1978) while in mouse mammary gland culture, 
cortisol is required for casein gene expression (Ganguly et al., 1980). Besides 
being a stimulator of milk protein synthesis, an anti-apoptotic role has also 
been suggested for glucocorticoids. Treatment with glucocorticoids during 
involution in mouse mammary gland reduced the extent of apoptosis (Feng et 
al., 1995) while in lactating rats, glucocorticoids prevented apoptosis (Berg et 
al., 2002).
1.4.7 Placental lactogen
Placental lactogen (PL) is secreted by placentas of primates, rodents and 
ruminants during pregnancy. It is structurally related to growth hormone and 
prolactin. It has been shown in mice that the degree of mammary development 
correlates with litter size and hence presumably with the concentration of PL
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(Knight and Peaker,1982). Similarly, in ruminants a positive correlation is 
observed. The concentration of circulating PL in sheep and goats was directly 
related to litter size and milk yield (Hayden et al.,1979; Butler et al.,1981). PL 
has been demonstrated to increase milk yield in lactating cows (Byatt et 
al.,1992). In sheep, ovine PL when administered in an established lactation, 
did not increase milk yield (Min et al.,1997), whereas, when administered to 
ewes that were artificially induced to lactate, milk yield was significantly 
increased (Kann et al., 1997). Mouse PL was also shown to stimulate a- 
lactalbumin secretion in mouse mammary epithelial cell cultures in a dose 
responsive manner and is more potent than either mouse or ovine prolactin 
(Thordarson et al.,1986).
Whether PL is mitogenic remains plausible. In vitro studies showed 
that PL stimulated proliferation of mouse mammary epithelial cells (Dai et 
al.,1996) while in ovine and rabbit cultures, P-casein synthesis was stimulated 
by PL instead. PL has also been demonstrated to stimulate IGF-1 expression in 
lactating cows (Byatt et al.,1992). In sheep, PL stimulated IGF-1 production in 
ewes that were artifically induced to lactate (Kann et al., 1999) but not 
pregnant sheep (Currie et al.,1996). The role of PL as a mitogen in the 
mammary gland requires more studies to provide a clearer picture.
1.5 GROWTH FACTORS AND MAMMARY DEVELOPMENT
In addition to systemic control by circulating hormones, there are a number of 
local factors that have been suggested to either complement or mediate 
hormonal control of mammary development and function.
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1.5.1 Insulin-like growth factors
The role of IGF-1 in mammary gland development is to mediate the actions of 
growth hormone (Kleinberg,1998). Studies demonstrated that IGF-1 can 
substitute for the pituitary gland in promoting mammary development and 
growth hormone increases the levels of IGF-1 mRNA in the mammary gland. 
Ruan et al. (1992) showed, in hypophysectomized, castrated and estradiol- 
treated prepubertal male rats, that when IGF-1 was implanted into the 
mammary gland, the development of terminal end buds and the formation of 
alveolar structures were induced. Next, using in-situ hybridisation, it was 
shown that IGF-1 and its receptor mRNA were expressed in the highly 
proliferative terminal end buds in pubertal murine mammary gland. 
Furthermore, when IGF-1 in combination with mammogenic hormones were 
added to the pubertal glands in vitro, ductal growth was again promoted. Other 
evidence includes the stimulation of bovine mammary epithelial cell 
proliferation in vitro (McGrath et al.,1991) and in vivo (Collier et al.,1993). 
Recently, using knockout models of the IGF system, the role of IGF-1 in the 
mammary gland was again demonstrated. When IGF-1 receptor null 
epithelium was transplanted into a wild-type cleared fat pad, there was limited 
growth of the epithelium (Hadsell and Bonnette,2000). On the other hand, 
during pregnancy, IGF-1 doesn’t seem to have an essential role since 
overexpression of rat IGF-1 in mammary alveolar cells did not affect 
mammary development (Neuenschwander et al.,1996).
Whether IGF-1 has a role during lactation remains debatable. It has 
been shown to be capable of stimulating milk protein gene expression in 
primary cultures of mammary cells (Prosser et al.,1987). Local infusion of
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IGF-1 in lactating goats was able to increase milk synthesis (Prosser et 
al.,1990) while systemic infusion did not obtain a similar response (Davis et 
al.,1989). In rats, treatment with exogenous IGF-1 did not increase milk 
synthesis (Flint et al.,1992) and in transgenic mice, overexpression of IGF-1 
during lactation results in ductal hypertrophy (Hadsell et al.,1996). It seems 
that whether IGF-1 has a role in lactation is dependent on the species.
IGF-1 has also been shown to be a more potent inhibitor of apoptosis 
than insulin in cell culture models (Geier et al.,1992). This role of IGF-1 was 
also demonstrated in the mammary gland. In vitro studies showed that IGF-1 
inhibits apoptosis (Farrelly et al.,1999). Neuenschwander et al.(1996) showed 
that when IGF-1 was over expressed in transgenic mice, mammary involution 
was inhibited.
1.5.2 Transforming growth factor a  and P
Transforming growth factor a  (TGFa) is a nonheparin-binding member of the 
epidermal growth factor receptor (EGFR) ligand family. TGFa overexpression 
is associated with some neoplastic cells and tissues and the fact that its mRNA 
is detected in the mammary gland at various stages of development raises 
interest as to what role TGFa might play in mammary development. The 
potential role of TGFa was demonstrated using organ cultures. When 
mammary tissue was cultured with TGFa in the presence of insulin, prolactin, 
aldosterone and hydrocortisone, it promoted the formation of full lobulo- 
alveolar structures which was not observed with the four mammogens alone 
(Vonderhaar,1988). Similarly, when pellets containing TGFa were implanted 
in the mammary gland in vivo, TGFa was able to stimulate local growth even 
in the absence of steroid supplement. Further studies carried out on TGFa
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transgenic mice showed that when this growth factor was overexpressed, it led 
to the development of precocious alveolar development and a marked decrease 
in postlactational involution (Schroeder and Lee, 1997). This led to the 
suggestion that TGFa might be involved in mammary gland tumorigenesis.
Transforming growth factor-p (TGF-p) belongs to a family of growth 
factors involved in regulating growth, differentiation and development in 
many organ systems (Roberts and Spom,1990). It exist in three isoforms and 
is expressed in all stages of mammary gland development except lactation 
(Robinson et al.,1991). TGF-p, when implanted locally in the mammary 
gland, inhibited mammary growth in virgin mice (Silberstein and Daniel, 1987) 
while in pregnant mice, ductal elongation was inhibited (Daniel et al.,1989). 
Other studies also showed that overexpressing TGF-p in pubertal mouse 
caused a reduction in the growth of the ductal tree and a simplification of the 
pattern of arborization. Besides that, this study also showed that when 
exogenous TGF-P was applied directly to the gland, not only was there an 
inhibition of DNA synthesis, extracellular matrix synthesis was strongly 
stimulated (Daniel et al.,1996). Despite all these observations, Soriano et 
al.(1998) showed that at low concentrations, TGF-p was capable of 
stimulating extensive elongation and branching of epithelial cords using an in 
vitro model. Nonetheless, at higher concentration TGF-p was still inhibitory. 
This biphasic effect of TGF-P might exist in vivo, however since a 
transformed mammary cell line was used in the Soriano experiment, it would 
be sensible to carry out further studies to establish this role of TGF-p.
Expression of TGF-P mRNA is elevated during mammary involution 
(Robinson et al.,1991), suggesting that TGF-p might have a role during that
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period. Recently, it was demonstrated that one of the TGF-P isoforms, TGF- 
P3 is strongly expressed during the second phase of the mouse mammary 
gland involution (Faure et al.,2000). Based on this observation, TGF-p3 might 
be involved in mammary gland remodelling since TGF-p does stimulate 
synthesis of the extracellular matrix.
1.5.3 Epidermal Growth Factor
Epidermal growth factor (EGF) belongs to the same family of growth factors 
as TGFa. EGF’s suggested role in the mammary gland is to act as a mitogen. 
By using slow-release pellets, EGF was demonstrated to stimulate local end 
bud growth in mammary glands of ovariectomised virgin mice in a dose- 
dependent manner (Daniel and Silberstein,1987). A similar study carried out 
by Vonderhaar (1988) reinforced this role of EGF. She showed that in 
ovariectomised virgin mice, primed with estrogen and progesterone, local 
implantation of EGF pellets induced both ductal elongation and lobulo- 
alveolar growth in the mammary gland, suggesting that EGF might act 
synergistically with estrogen and progesterone. Interestingly, treatment with 
estrogen and progesterone of pubertal mice resulted in an increase in EGF 
receptor (EGFR) concentration (Haslam et al.,1992). The expression of EGF 
and its receptor has been detected in the mammary gland at all stages of 
development. Immunoblot analysis carried out by Darcy et al. (1999) showed 
that high levels of EGFR are expressed during puberty, pregnancy, involution 
but not during lactation. This group also demonstrated that EGFR signalling 
was required for growth, differentiation and survival but not for maintaining 
functional differentiation of mammary epithelial cells. In fact, when mouse 
mammary epithelial cells were cultured in the presence of EGF, besides
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stimulating proliferation, the synthesis of milk was also inhibited (Tonelli and 
Sorof,1980). EGF thus might have an antagonistic role during lactation. 
Indeed, prolactin was shown to inhibit EGF-stimulated DNA synthesis in vitro 
(Fenton and Sheffield, 1993; Sheffield, 1998). EGF was also shown to suppress 
Stat 5 expression in vitro (Petersen and Haldosen,1998). Based on all these 
observations, EGF might have an essential role during pregnancy, possibly to 
ensure that the mammary gland is well-developed before allowing the onset of 
lactation.
1.5.4 Fibroblast growth factors
Fibroblast growth factors (FGF) belong to the group of heparin-binding 
growth factors. Studies have shown that FGF is capable of stimulating growth 
of mammary cells. Bovine FGF stimulated the growth of stromal and 
myoepithelial-like cells in the rat mammary gland (Smith et al.,1984), and 
when added to human breast cancer cells, T47D, there was a significant 
increase in growth rate (Shiu,1981). Besides that, FGF and its receptors have 
also been detected in the mouse mammary gland (Coleman-Kmacik and 
Rosen, 1994). Jackson et al. (1997) also showed that when dominant negative 
FGF receptors were created in mice, depressed lobulo-alveolar development 
was observed during pregnancy. In contrast, FGF did not stimulate 
proliferation in caprine mammary epithelial cells, suggesting a species- 
dependent response (Pantschenko and Yang, 1999).
Besides having a growth promoting role, FGF has also been shown to 
inhibit the expression of milk proteins in the presence of lactogenic hormones 
(Levay-Young et al.,1989). With this observation, FGF might have a similar 
role as EGF during pregnancy, which is to prevent precocious differentiation.
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1.6 PARACRINE SIGNALLING IN THE MAMMARY GLAND
Over the past two decades, evidence has increased indicating the involvement 
of paracrine regulation in mammary gland development.
1.6.1 Adipocyte-epithelial interactions
Pioneering studies by Kratochwil (1971&1977) and Sakakura et al.(1976) 
demonstrated that morphogenic development of the mammary epithelium is 
dependent on mesenchyme. When 16-day fetal mammary epithelium was 
recombined with mesenchyma of either mammary or salivary origin, a 
branching pattern characteristic of the source of mesenchyma was observed.
The major cell-cell interaction in the mammary gland after birth is 
between epithelium and adipocytes. The possibility that adipocytes exert a 
growth-promoting effect on mammary epithelium has been demonstrated 
through transplantation experiments (DeOme et al.,1959; Hoshino,1962). 
Besides that, Levine and Stockdale (1984) also showed that when mammary 
epithelial cells derived from mid-pregnant mice were co-cultured with the 
adipocyte cell line 3T3-L1, mammary cell growth was significantly higher 
than when those mammary cells were cultured on tissue culture plates. He also 
showed that when lactogenic hormones were added to the co-cultures, the 
mammary epithelial cells became differentiated and synthesized casein 
(Levine and Stockdale, 1985). Recently, using mammary epithelial organoids 
(MEO) isolated from pubescent rats, adipocytes were again shown to enhance 
functional differentiation (Zangani et al.,1999). During ductal growth, 
migratory white blood cells, macrophages and eosinophils are recruited to the 
end buds and this has been indicated to be essential for development of the end 
buds (Gouon-Evans et al.,2000). Interestingly, DNA synthesis in the stroma is
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detected during this activity, suggesting its involvement in the response 
(Berger and Daniel, 1983).
Studies have indicated that the stromal component could exert its effect 
by being a necessary target for endocrine mammogens and a site for synthesis 
of stimulatory growth factors. In the mouse mammary gland, estrogen 
receptors are expressed both in the epithelial and stromal cells (Fendrick et 
al.,1998). Using tissue recombinations and estrogen-receptor knockout 
(ERKO) mice, Cunha et al.(1997) demonstrated that when ERKO mammary 
epithelium was grown in wild-type fat pad, the ERKO mammary epithelium 
underwent extensive ductal growth and branching morphogenesis. However, 
this was not observed in tissue recombinants containing wild-type mammary 
epithelium and ERKO fat pad. In addition, when adult mammary stroma was 
recombined with immature epithelium tissue, there was an induction of the 
progesterone receptor (Woodward et al.,1998), thus a role for the maintenance 
of oestrogen-responsiveness by the stroma is not dismissible. From these 
observations, there seems to be a critical role of stromal estrogen receptors in 
estrogen-dependent epithelial responses.
Evidence has also presented that progesterone might elicit a response 
within the mammary fat pad. Using local implants, progesterone induced 
stromal proliferation in mature female mice (Wang et al.,1990). Growth 
hormone (GH) actions have also been suggested to be mediated by stromal 
cells. Exogenous GH up-regulates IGF-1 expression in the fat pad 
(Kleinberg,1998), which was also detected in bovine mammary adipose tissue 
upon GH treatment in vitro (Akers et al.,2000).
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Compelling evidence supports the mammary fat pad as a site for the 
synthesis of growth factors. Studies have demonstrated that IGF-1 is actually 
stroma-derived in the rodent, ruminant and human mammary gland (Hovey et 
al.,1998; Kleinberg,1998; Rasmussen and Cullen, 1998). As for EGF receptors, 
besides being present on epithelial cells, they are also detected within the 
mouse mammary fat pad. Haslam et al.(1993) demonstrated that locally 
implanted EGF pellets in the mammary gland of ovariectomised mature 
female mice, not only stimulated DNA synthesis in the epithelial cells but also 
in the stromal cells. When the EGF receptors in the stromal cells were not 
present, normal ductal morphogenesis could not proceed (Sebastian et 
al.,1998). Stromal expression of the second member of the FGF family, basic 
FGF (bFGF), has been shown to be enhanced by the surrounding parenchyma 
(Coleman-Kmacik and Rosen, 1994; Hovey et al.,1996), suggesting paracrine 
interactions.
Besides the regular growth factors mentioned above, the stroma is 
known to express other growth regulators. The Wnt gene family members are 
known to be expressed in the fat pad under the influence of ovarian hormones 
(Weber-Hall et al.,1994). Heregulin, the neu-differentiation factor has also 
been demonstrated to be expressed in the perialveolar stroma during 
pregnancy and is capable of inducing lobulo-alveolar growth and milk protein 
synthesis in vitro (Birchmeier and Birchmeier,1998).
From all the evidence gathered from these studies, we see that the 
mammary fat pad, rather than being an inert supporting matrix, is a key player 
in normal mammary gland development and function.
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1.6.2 Extracellular matrix and cell interactions
The extracellular matrix (ECM) is composed of collagen, laminin, fibronectin, 
proteoglycan and elastin. The importance of ECM in mammary gland 
development and function has become increasingly evident, ECM proteins 
having been shown to be involved in the regulation of mammary epithelial cell 
proliferation, differentiation and apoptosis. Keely et al.(1995) demonstrated 
that collagen I, collagen IV and laminin mRNAs are expressed temporally in 
the mammary gland and this expression pattern corresponds with the stage of 
mammary development where active proliferation occurs. In another study, 
fibronectin and fibronectin-specific integrin, aspi, were shown to have the 
highest expression during active proliferation and lowest during non­
proliferative phases and lactation in the mouse mammary gland (Woodward et 
al.,2001). In addition, this group also demonstrated that when the mice were 
ovariectomised, fibronectin expression was decreased by 70%, indicating that 
fibronectin might be an effector of hormone-dependent proliferation in the 
mouse mammary gland. Progesterone stimulated proliferation of mammary 
epithelial cells has also been demonstrated to be influenced by fibronectin and 
collagen IV (Xie and Haslam, 1997). When mouse mammary epithelial cells 
were cultured in the presence of ECM proteins, these promoted a highly 
synergistic proliferative response to EGF plus IGF-1 (Woodward et al.,2000). 
In contrast, when human breast cancer cells were cultured on laminin, 
estrogen-induced proliferation was greatly reduced (Woodward et al.,2000), 
indicating that specific ECM proteins might be involved in stimulating 
proliferation in mammary epithelial cells.
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ECM’s role in differentiation of mammary epithelial cell was 
demonstrated by pioneering studies carried out in the 1970s (Emerman et 
al.,1977; Emerman and Pitelka,1977). These studies showed that mammary 
epithelial cells derived from pregnant mice, when cultured in the presence of 
lactogenic hormone, only synthesized milk proteins. However when these 
cells were cultured on a floating collagen gel, in addition to milk protein 
synthesis, they became polarized and demonstrated ultrastructures reminiscent 
of luminal mammary cells in lactating animals. This role of the basement 
membrane was further supported by studies carried out over the years (Blum 
et al.,1987; Aggeler et al.,1988; Barcellos-Hoff et al.,1989). The results from 
these studies consistently showed that when mammary epithelial cells were 
cultured on basement membrane, milk protein expression was significantly 
induced and if the cells were only cultured on plastic or non-released collagen 
gels, little or no milk proteins were detected even in the presence of lactogenic 
hormones. These studies also demonstrated that besides collagen gels, 
basement membrane matrix derived from Engelbreth-Holm-Swarm tumour 
(EHS matrix) is also capable of inducing such a response. When mammary 
epithelial cells are cultured on EHS matrix, in addition to high level milk 
production, the cells formed spherical structures that resemble the alveoli in 
the lactating gland. ECM exerts its effect on mammary epithelial cell 
differentiation through the induction of milk protein gene expression. 
Laminin-rich basement substratum was shown to induce P-casein expression 
via integrins since anti-integrin antibody severely diminished its synthesis 
(Streuli et al.,1991; Streuli and Edwards, 1998).
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In addition to its role in proliferation and differentiation of mammary 
epithelial cells, ECM has also been implicated as a regulator of apoptosis. 
Basement membrane extracellular matrix was shown to suppress apoptosis of 
mammary epithelial cells both in vitro and in vivo (Boudreau et al.,1995). 
They demonstrated that when ECM degradation was induced, apoptosis in 
these cells was initiated, and when pi integrins were blocked by antibodies, a 
similar effect was observed. Furthermore, one of the inducers of apoptosis, 
interleukin-ip converting enzyme (ICE) was also shown to be expressed 
during ECM- induced apoptosis. From this study we can say that ECM 
regulates apoptosis in mammary epithelial cells through an integrin-dependent 
negative regulation of ICE expression. Pullan et al.(1996) demonstrated that 
primary mammary epithelial cells cultured on laminin-rich membrane but not 
collagen I, did not apoptose. Recently, ECM role in mammary epithelial cell 
apoptosis was further demonstrated. Besides showing the requirement of 
integrins (<X6pi), insulin or insulin-like growth factors were also shown to be 
essential to suppress mammary cell apoptosis (Farrelly et al.,1999). This 
indicates that basement membrane and soluble factors coordinately regulate 
cell survival signals in mammary epithelial cells.
1.6.3 Fibroblast-epithelial cell interactions
The effect of estrogen on mammary epithelial cell proliferation in vivo has 
been well established. However, this effect could not be demonstrated in vitro. 
This led to the suggestion that estrogen’s effect might be mediated through the 
stroma. Interestingly, mammary fibroblasts have been shown to express the 
estrogen receptor (Haslam and Levely,1985). Besides that, it was also shown 
that when mammary epithelial cells and mammary fibroblasts were cultured in
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mixed cultures, estrogen was able to induce progesterone receptor 
concentration, which was not observed if mammary epithelial cells were 
cultured alone. In addition, Haslam (1986) also demonstrated that estrogen- 
dependent DNA synthesis in mammary epithelial cells only occurs in the 
presence of mammary fibroblasts which is consistent with earlier studies 
(McGrath, 1983). Fibroblasts were later shown to stimulate proliferation of 
normal and neoplastic human mammary epithelial cells (Gache et al.,1998). 
Recently, Darcy et al.(2000) indicated that fibroblasts not only stimulated 
proliferation but also alveolar morphogenesis and functional differentiation in 
rat mammary epithelial cells.
1.7 LEPTIN
Leptin and its receptor were identified in parabiosis studies carried out in the 
1970s using two strains of mutant mice, obese (ob) and diabetes (db) 
(Coleman, 1973; Coleman, 1978). Both strains of mice exhibit obesity, 
hyperglycemia and insulin resistance resembling type II diabetes when 
homozygous for these mutations. Parabiosis of an ob/ob mouse and a lean 
mouse resulted in partial normalization of body weight in the ob/ob mutant 
mice, leading to the suggestion that ob/ob mice were deficient in a circulating 
factor that is present in the blood of the lean animal. Using positional cloning, 
the ob gene and its product were later identified (Zhang et al.,1994). The ob 
gene product, leptin, is a 16KDa protein expressed mainly in adipose tissue.
1.7.1 Leptin receptor
The identification of the leptin receptor (OB-R) was achieved using an 
expression cloning strategy (Tartaglia et al.,1995). OB-R belongs to the class I
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cytokine receptor family. Due to alternate splicing, at least five isoforms of the 
receptor exist (Lostao et al.,1998), which can be generally grouped into long 
and short forms of the receptor. The extracellular domains of the various 
isoforms of OB-R are identical throughout their entire length, differences arise 
in the intracellular domain, where the long form contains sequence motifs 
indicating intracellular signalling capabilities. Indeed, the long-form OB-R 
(Ob-Rb) has been demonstrated to activate Janus kinase 2, which in turn 
activates STAT proteins, in response to ligand binding (Tartaglia,1997; White 
et al.,1997). In addition, leptin was also able to stimulate insulin receptor 
substrate phosphorylation (Bjorbaek et al.,1997), PI3 kinase activity (Wang et 
al.,1997; Kim et al.,2000) and MAPK (ERK) activity (Takahashi et al.,1997). 
Even though the short-form OB-R does not possess potential signalling 
domains, it has been demonstrated to be capable of modulating signalling in 
the long-form receptor (White et al.,1997), raising the idea that the short-form 
receptor might have a regulatory role.
1.7.2 Leptin as a satiety factor
Mice deficient in leptin are severely obese while mice expressing a defective 
leptin receptor, in addition to being obese, are resistant to leptin (Chen et 
al.,1996; Iida et al.,1996; Marti et al.,1999). Moreover, leptin mRNA and 
protein expression have been demonstrated to be influenced by alteration in 
food-intake (reviewed in Tartaglia,1997). Fasting results in dramatic down- 
regulation of leptin expression whereas an increase in caloric intake results in 
up-regulation. The breakthrough came when it was shown that administration 
of leptin in rodents was capable of reducing food-intake and inducing weight
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loss (Campfield et al.,1995; Halaas et al.,1995). All these observations led to 
the implication that leptin is a satiety factor.
In ruminants, in this case sheep, leptin gene expression in adipose 
tissue was also correlated with body fatness and food intake (reviewed by 
Chilliard, 2001). Leptin mRNA level in adipose tissue was higher in sheep 
from a fat selection line when compared with lean counterparts. In addition, 
level of adipose tissue leptin mRNA was also sharply decreased by food 
deprivation/undemutrition and increased by refeeding.
Expression of the long-form leptin receptor has been detected in the 
hypothalamus. Its expression has been localized in the arcuate (ARC) and 
paraventricular (PVN) nuclei as well as in ventromedial (VMH), lateral (LH) 
and dorsomedial (DMM) hypothalamic areas (Marti et al.,1999). Of particular 
interest is the PVN since it regulates body weight and/or food intake (Flier and 
Maratos-Flier,1998). The effects of leptin on body weight are thought to be 
mediated via the hypothalamus. Within the hypothalamus, leptin decreases 
expression of the orexegenic peptides, neuropeptide Y (NPY) and agouti- 
related peptide (AgRP), and increases expression of the anorexigenic peptides, 
POMC and CART, resulting in a decrease in appetite (reviewed in Vernon et 
al.,2001).
In addtion to its central effects on food intake, leptin is also required 
for normal reproduction and immune function (Ahima and Flier,2000). 
However, we must note that leptin’s role in reproduction was only observed in 
ob/ob mice and is not a limiting factor in most species.
Leptin has also been demonstrated to target peripheral tissues. Leptin 
has a lipolytic effect on adipocytes in rodents (Friihbeck et al.,1997; Friihbeck
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et al.,1998; Kawaji et al.,2001; Marti et al.,2001) but not in sheep (Newby et 
al., 2001), it also alters the ability of preadipocytes to respond to lipogenic 
hormones (Bai et al.,1996) and induces proliferation, differentiation and 
functional activation of hemopoietic cells (Gainsford et al.,1996). As leptin 
seems to have diverse roles and is secreted by adipocytes, it would be 
interesting to investigate if leptin has a role in the mammary gland.
1.7.3 Leptin and the mammary gland
Besides being expressed in the hypothalamus, leptin and its receptor have also 
been detected in many other tissues including the mammary gland. Aoki et al.
(1999) demonstrated that leptin is expressed in the mouse mammary gland. 
By using RT-PCR, they showed that expression of leptin is detected as early 
as in the virgin stage. This level of expression decreases as the animal goes 
into gestation and lactation. After lactation, the level of expression is restored 
to that of the virgin stage. In addition, this group showed that the mouse 
mammary cell line, COMMA-ID, also expresses leptin and this expression is 
reduced significantly when the cells are cultured in the presence of prolactin. 
A separate study carried out in ruminants showed that leptin (Bonnet et 
al.,2002), and both the long and short forms of its receptor (Laud et al.,1999) 
are expressed in the ovine mammary gland. In-situ hybridisation localized the 
expression of the receptor to the alveolar epithelial cells (Laud et al.,1999). 
Bonnet et al.(2002) using immunohisotchemistry showed that the cellular 
location of leptin in the ovine mammary gland changes during different phases 
of development. During early stages of development, leptin was exclusively 
located in mammary adipocytes and just before parturition, it was present in 
mammary epithelial cells. During lactation, leptin was located in
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myoepithelial cells. This is an intriguing observation since it suggests that 
paracrine signalling might be occurring between different cell types during 
different stages of development. In both studies, expression of leptin and its 
receptor also decreases as the animal goes into lactation. Based on all of these 
observations, we can see that the expression of leptin and its receptor seems to 
be down-regulated during lactation. Besides rodents and ruminants, human 
mammary epithelial cells have also been shown to express leptin (Smith- 
Kirwin et al.,1998). Leptin was detected in human mammary tissue, cultured 
human mammary cells and secretory epithelial cells from breast milk. 
Interestingly, ob mice have been claimed to be incapable of lactating (Chehab 
et al.,1996). Ob mice are known to be sterile and in this particular study, it was 
shown that leptin treatment was able to restore fertilty, but these mice still lack 
the capability to secrete milk. Here, it seems like leptin might have a role in 
early mammary development. Indeed, it has been shown that mammary 
development in ob mice is seriously compromised (Knight and 
Sorensen,2001). In a different study, leptin was shown to partly inhibit IGF-1 
and foetal bovine serum (FBS)-stimulated proliferation in the bovine 
mammary epithelial cell line, MAC-T (Silva and VandeHaar,1999).
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1.8 AIM OF THE STUDY
This review has discussed the importance and contribution of both 
local and endocrine controls in mammary gland development and function. 
Besides that we have also established the fact that there is an obligatory 
requirement, especially during early development, for the mammary fat pad.
Since the fat pad influences ductal growth; the number of mammary 
epithelial cells is a major determinant of milk yield and it also influences the 
incidence of mammary gland lesions, our first objective is to examine factors 
such as proliferation and apoptosis in the mouse mammary gland during 
different stages of development.
As both leptin and its receptor are expressed in the mammary gland, 
our second objective is to examine the hypothesis that leptin is an obligate 
growth factor for mammary development. To address this, a combination of in 
vitro and in vivo models were employed
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CHAPTER TWO 
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Chemicals
Unless otherwise stated, laboratory chemicals and apparatus were supplied by 
Sigma-Aldrich Company Ltd., Poole, UK and Merck Ltd., Poole, UK. Cell 
culture consumables were obtained from Greiner Bio-One Ltd., 
Gloucestershire, UK while culture media was purchased from Life 
Technologies Ltd., Paisley, UK. Deionised water for general laboratory use 
was purified by reverse osmosis, ion/organic removal and photo-oxidation. 
Water used for tissue culture was ultrafiltered and further photo-oxidated to
18.2 mOhms resistance.
2.1.2 Radiochemicals
Radiochemicals were from Sigma-Aldrich Company Ltd., Poole, UK ; ICN 
Pharmaceuticals Ltd., Basingstoke, UK or NEN Dupont Ltd., Stevenage, UK. 
14C-, 3H- and 35S- activities were determined using a 1600TR liquid 
scintillation analyser with Emulsifier-Safe™ scintillation fluid (both from 
Canberra Packard, Berkshire, UK).
2.1.3 Animals
Mice (Tucks number one strain, A. Tuck and Son, Essex, UK) were housed 
individually in an animal house under a 12h light-dark cycle, and had diet 
CRMX (SDS, Manea, Cambridgeshire, UK) and tap water available ad 
libitum.
British Saanen goats in their third trimester of pregnancy (dl07-dl24) were 
obtained from A&K Wielkopolski, St. Helen’s Farm, York, UK. They were
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kept in the Institute’s goat house and fed an 18% crude protein concentrate 
with hay and water available ad libitum.
2.2 HISTOCHEMISTRY AND IMMUNOHISTOCHEMISTRY
2.2.1 Coating of slides
Silane coated slides were prepared by first washing the slides in 5% (v/v) 
Decon for 30min, followed by rinsing thoroughly with tap water and deionised 
water. The slides were then incubated in absolute alcohol for lmin, 2% (v/v) 
3-aminopropyltriethoxysilane (APES) in absolute alcohol for 30sec and then 
in absolute alcohol for lmin. Finally, the slides were washed in deionised 
water and left to dry overnight at room temperature.
2.2.2 Fixation of mammary tissue for immunohistochemistry
The inguinal glands were fixed overnight in 10% formalin and stored in 70% 
(v/v) ethanol until treated according to a standard dehydration/embedding 
protocol (Kieman,1981). Tissues were first washed in absolute alcohol at 
room temperature for 6h with 3 changes of ethanol, followed by one 2h wash 
with absolute ethanol:chloroform (1:1,v/v) and finally washed in chloroform 
for lh. After washing, the tissues were incubated in paraffin wax. To allow 
immunohistochemistry analysis, tissues were processed into 4pm thick 
sections on a microtome (Reichert-Jung, 2040 Autocut, Nussloch, Germany) 
using disposable steel blades (Leica model 819, Nussloch, Germany). Sections 
were floated onto a waterbath set at 50°C, then mounted onto silane-coated 
slides and air dried overnight.
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2.2.3 Fixation of mammary gland for wholemount analysis
In this method the entire mammary gland was spread onto a silane coated slide 
and fixed in Camoy’s fixative (60% (v/v) absolute alcohol: 30% (v/v) 
chloroform: 10% (v/v) glacial acetic acid) for 2 to 4 h at room temperature. 
Next, the slide was subjected to a series of 15min washes starting with 
70%(v/v) ethanol ; 50% (v/v) ethanol ; 25%(v/v) ethanol and finally with 
distilled water . The mammary gland was then stained overnight with carmine 
alum (0.2%(w/v) carmine and 0.5%(w/v) aluminium potassium sulphate). 
After staining, it was dehydrated by washing for 15min in 70% ethanol, 95% 
ethanol and absolute alcohol respectively. Finally, the mammary gland was 
cleared in histoclear and mounted with DPX mounting medium (Agar 
Scientific, Standsted, UK).
2.2.4 Fixation and sectioning of mammospheres
Culture medium was removed from cells on EHS matrix and ~300pl replaced. 
An equal volume of fixation solution (4% (w/v) paraformaldehyde in 0.1M 
phosphate buffer) was added for 30min. This was replaced twice more with 
fresh fixation solution. The cells were then washed three times for lOmins 
with rinse solution (0.1M phosphate buffer containing 2% (w/v) sucrose and
0.002% (w/v) C aC y. Cells were gently scraped from the plate and transferred 
to a cryotube containing ~100pl of OCT compound (Agar Scientific, 
Standsted, UK). The tube was left to stand for ~ lhr to allow the cells to settle. 
Excess rinse buffer was removed and further OCT compound was added, into 
which the cells were gently mixed. The sample was frozen slowly (-l°C/min) 
at -70°C. 4pm sections were cut on a cryostat (Leica CM 1800, Cambridge,
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UK), transferred onto silane-coated microscope slides and allowed to air-dry 
overnight.
2.2.5 Immunostaining for milk proteins
Sections were preblocked in PBS/0.1% Tween 20 (PBST) containing 0.1% 
(v/v) Triton and 0.3% (w/v) BSA for 20min. Non-antigenic sites were then 
blocked with PBST containing 25% (v/v) donkey non-immune serum for 
30min. The sections were then incubated with sheep anti- bovine casein 
(Guildhay Ltd, Surrey, UK) diluted 1:250, and rabbit anti-bovine P- 
lactoglobulin (Bethyl Laboratories Inc., Texas, USA) diluted 1:250 in PBST 
for 2h at 37°C in a humified chamber. Sections were then washed three times 
in PBST, followed by incubation with donkey anti-sheep and anti-rabbit 
fluoroscein isothiocyanate (SAPU, Lanarkshire, UK) diluted 1:500 for 2h at 
37°C in a humified chamber. The sections were washed as before and mounted 
with Vectashield (Vector Laboratories, Peterborough, UK) containing 4,6- 
diamidino-2-phenylindole (DAPI) nuclear stain (1.5pg/ml). The cells were 
visualised by fluorescence microscopy (Leitz DMRB, Leica, Cambridge, UK).
2.2.6 Counterstaining of paraffin-embedded tissue sections 
Paraffin-embedded sections were dewaxed in histoclear and rehydrated 
through a graded series of ethanol and water (Stevens, 1990). Rehydrated 
sections were placed in Mayers hematoxylin (Sigma, Poole, UK) for 5min and 
rinsed in water. To develop the dye, the sections were placed in a solution of 
LiCb (Scott’s tap water, Sigma, Poole, UK) until all the cell nuclei turned 
blue. Sections were washed in deionised water; dehydrated in 70% (v/v) 
ethanol, 90% (v/v) ethanol and absolute ethanol; cleared and mounted as 
described in section 2.2.3.
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2.2.7 Detection of BrdU incorporation
BrdU incorporation was detected by immunohistochemistry using the indirect 
horseradish peroxidase (HRP) conjugated Streptavidin-biotin staining 
techniques as described and supplied by DAKO Ltd, Cambridge, UK. 
Paraffin-embedded sections were dewaxed and rehydrated as described in 
section 2.2.6. Sections were then washed in PBS for 5min followed by 
incubating in pronase prepared in PBS (50pg/ml) for 5min at 37°C and again 
washed in PBS for 5min. To quench any peroxidase activity that might be 
present, the sections were treated with 2% (v/v) H2O2 in methanol for 5min at 
room temperature. Sections were incubated with 2M HC1 for lh  at 37°C to 
denature the DNA. They were then washed in PBS and treated with 0.2% 
Triton X-100 for 30min at RT. Sections were again washed in PBS for 5min 
and to prevent non-specific binding, they were incubated with normal rabbit 
serum (Scottish Antibody Production Unit (SAPU), Lanarkshire, UK) diluted 
1:10 with Tris-HCl pH7.6 for 20min at RT and followed by 5min wash in 
PBS. After blocking, the sections were incubated with primary antibody, 
mouse anti-BrdU diluted 1:20 with BSA/PBS (0.5%(w/v) BSA in PBS), for lh 
at RT in a humified chamber. Unbound antibodies were removed by washing 
the sections in PBS for lOmin. Next the sections were incubated with 
biotinylated rabbit anti-mouse immunoglobulin diluted 1:1000 with 0.5% 
BSA/PBS, for 45min at RT in a humified chamber. The avidin-biotin complex 
was applied to sections for 45min followed by washing in PBS. The bound 
antibody was detected by incubating sections with DAB solution prepared as 
recommended by manufacturer (Sigma, Poole, UK). The colour reaction was 
monitored under the microscope and upon detection sections were washed in
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deionised water. Finally, the sections were counterstained, developed, 
dehydrated, cleared and mounted as described in section 2.2.6.
2.2.8 In Situ Apoptosis detection
Apoptotic cells on tissue sections were detected using the ApopTag 
Peroxidase apoptosis kit (Intergen Co., Oxford, UK) according to 
manufacturer’s instructions. Histological sections were dewaxed and 
rehydrated as described in section 2.2.4. To remove DNA-binding protein, the 
sections were incubated with a protein digesting enzyme or Proteinase K 
(20pg/ml) for 15min at RT and then washed in two changes of dctfUO for 
4min. Next the sections were treated with 2% (v/v) H2O2 in PBS for 5min at 
RT so as to block endogenous peroxidase activity. Sections were then rinsed 
in PBS and immersed in an equilibration buffer before incubating with 
terminal deoxynucleotidyl transferase for lh in a humified chamber at 37°C. 
To stop the reaction, the slides were transferred to stop/wash buffer (provided 
by kit), preheated to 37°C, for lOmin at RT. Following this, the sections were 
rinsed in PBS and incubated with the peroxidase conjugated anti-dioxigenin 
antibody for 30min at RT. To detect apoptotic cells, the sections were again 
incubated with the substrate DAB. Finally, the sections were counterstained 
and mounted as described in 2.2.6.
2.2.9 Quantification of apoptosis and BrdU incorporation
Cells stained positive for apoptosis and BrdU incorporation were quantified 
using an image analysis system (Leica Q500MC, Nussloch, Germany). For 
each sample, three consecutive sections were prepared and mounted onto a 
slide. Cells from each section were counted by taking 12 separated views 
under the microscope. Results obtained were the mean of the three sections
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and were expressed as a percentage of positive cells out of the total cells 
counted.
2.3 CULTURE OF CAPRINE MAMMARY CELLS
The approach comprised collection of mammary tissue from mid-pregnant 
goats followed by digestion to yield cell clumps suitable for cryo-preservation. 
Subsequently these cells were cultured on plastic (proliferation phase) and 
then on Engelbreth-Holm-Swarm (EHS) matrix (differentiation phase) to yield 
structures anatomically similar to alveoli, termed mammospheres.
2.3.1 Preparation of EHS matrix
EHS matrix was prepared from Engelbreth-Holm-Swarm sarcoma passaged in 
lathyritic C57/BL mice by a method adapted from Kleinman et al (1986). 
Frozen tissue kept at -70°C was washed by homogenising (Ultra-Turrax T25, 
Janke & Kunkel, IKA Labortechnik) in 50mM Tris HC1 containing 4mM 
EDTA and 3.4M NaCl and centrifuged at 45,000 g for 30min at 4°C. This was 
repeated twice, before overnight extraction with 50mM Tris HC1 containing 
4mM EDTA, 2M urea and 0.2M NaCl. The resulting extract was centrifuged 
as before and the supernatant was dialysed [molecular weight cut-off 
(MWCO) 12-14 kDa] first against 50mM Tris HC1 containing 4mM EDTA 
and 0.15M NaCl (48h, 3 changes), and then with Dulbecco’s Modified Eagle’s 
medium (DMEM) containing lOmM Hepes buffer and penicillin/streptomycin 
(200U/ml and 200pg/ml respectively) for 16h. The dialysate was stored in 
aliquots at -20°C.
2.3.2 Cell culture media
The composition of the basal medium is shown in Table 2.1. Basal media (pH 
7.4) was sterilised through a 0.2pm pore filter (Gelman Sciences,
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Southampton,UK) and stored at 4°C. To prepare digestion medium, trypsin 
inhibitor, collagenase (Type 2, Worthington Biochemical Corporation, New 
Jersey, USA), hyaluronidase, DNase I (both Boehringer Mannheim Ltd, UK) 
were added to the basal media on day of use. Insulin was prepared by 
dissolving lOmg of insulin (from bovine pancreas, 27.4 USP units/mg) in 
10ml of deionised water followed by lOOpl of 0.34M NaOH and finally 
diluted with deionised water to lOOpg/ml. Cortisol was dissolved in absolute 
alcohol and again diluted with deionised water to lOOpg/ml. Both stocks of 
insulin and cortisol were stored in aliquots at -20°C , and added to the basal 
medium on the day of use.
2.3.3 Preparation of mammary epithelial cells
Goats in their third trimester of pregnancy (dl07-dl24) were culled by captive 
bolt, followed by exsanguination. The mammary gland was scrubbed with 
Hibitane™ (Zeneca Ltd, Cheshire, UK) and subsequently with 70% ethanol 
before excision. Once removed, it was trimmed of skin, cistern, ductal tissue
■j
and fat. The remaining tissue was cut into ~2cm pieces and immersed in 
sterile Hanks Balanced Salt Solution (HBSS; pH 7.4, 37°C). The tissue was 
washed twice in sterile HBSS, prior to removal of residual fat and connective 
tissue.
The tissue was cut into smaller pieces (~0.5cm3) and injected with 
digestion medium (Table 2.1) using a 21g needle. Tissue (80-100 g) was then 
incubated in digestion medium (4ml/g) at 37°C in an orbital incubator 
(Gallenkamp, Loughborough, UK) shaking at 120 rpm. After approximately 
lh, the tissue was recovered and chopped finely with curved scissors, before 
being returned to the digestion medium.
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After approximately 3-4h, when the cells were predominately in 
clumps of ~50 cells, the digest mixture was filtered through a 150pm pore 
nylon mesh (Lockertex, Warrington, UK). To harvest the cells , they were 
centrifuged at 80 g for 5min, resuspended in wash medium and re-harvested. 
This wash step was repeated three more times and the final cell pellet was 
resuspended in HBSS. Undigested material was subjected to further digestion 
(l-2h) after which cell harvesting was repeated.
Percoll fractions were prepared comprising Medium 199 containing 
20mM Hepes, 2%(w/v) Ficoll and Percoll to densities of 1.01-1.08 g/ml in 
increments of 0.01 g/ml. A discontinous gradient was prepared by gently 
layering 5ml of each fraction into a 50ml centrifuge tube. 5ml of cell 
suspension was gently layered on top and the gradient was centrifuged (800 g, 
20min, without braking). Individual bands were removed sequentially. The 
resulting cell suspensions were diluted with HBSS and centrifuged (100 g, 
lOmin) to remove the Percoll. The cells were washed once again by 
resuspending in HBSS and centrifuging (80 g, 5min). Finally, the cell pellet 
was resuspended in culture medium.
43
Table 2.1 Composition of media used in the isolation of caprine mammary
epithelial cells.
Digestion medium Wash medium
Basal medium
HBSS1 lx lx
MEAA2 lx lx
Glutamine (mM) 2 2
D-glucose (mM) 5.5 5.5
Bovine Serum Albumin 40 -
(mg/ml) 2.2 2.2
Calcium chloride (jig/ml) 2.5 2.5
Magnesium sulphate 120 120
(pg/ml) 100 100
Penicillin (pg/ml) 2.5 2.5
Kanamycin (pg/ml) - 5.4
Fungizone (pg/ml)
Hepes buffer (mM)
Hormones
Insulin (pg/ml) 5 5
Cortisol (pg/ml) 1 1
Enzymes
Collagenase (mg/ml) 1.2 -
Hyaluronidase (mg/ml) 0.5 -
Dnase I (pg/ml) - 20
Trypsin inhibitor (pg/ml) 100
1 Hanks Basal Salt Solution
2Minimum Essential Amino Acids
3Type II, ~ 330u/mg
44
2.3.4 Estimation of cell yield
Cell yield was estimated by pelleting lOOpl of the final cell suspension in an 
elongated microtube (13,000 g, 30s). The volume of the cell pellet was 
determined from the pellet dimensions, and cell number estimated with the aid 
of a standard plot determined by fluorometric measurement of DNA (Section 
2.7).
2.3.5 DNA assay
DNA content (as a measure of cell number) was measured by a fluorometric 
procedure (Labarca and Paigen, 1980). This assay is based on the binding of a 
florescent dye, bisbenzimide (Hoechst 33258), to DNA. Pelleted cells were 
sonicated (15s at setting 30; Kontes micro-ultrasonic cell disruptor, Burkard 
Scientific, Rickmansworth, UK) in 400pl DNA assay buffer (0.1M Na2HPC>4 
containing 2M NaCl, pH 7.4) and an appropriate volume was removed for 
assay. DNA standards (calf thymus) were prepared (range 0-5 pg) and all assay 
volumes were made up to 1ml with assay buffer before addition of 0.5ml of 
fluorescent reagent (3 jig/ml). Assay samples were incubated for lhr after 
which fluorescence was measured on a model LS-5 luminescence 
spectrometer (Perkin-Elmer Ltd., Beaconsfield, UK) with an excitation 
wavelength of 360nm, an emission wavelength of 475nm.
2.3.6 Cryopreservation of mammary epithelial cells
Cells were pelleted (80 g, 5min) and resuspended in foetal calf serum (37°C) 
containing 10% (v/v) dimethyl sulphoxide (DMSO) at a cell density of 2 x 107 
cells/ml. Cells were dispensed into cryovials and frozen slowly (-l°C/min). 
Once frozen, they were transferred to liquid nitrogen for long term storage.
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2.3.7 Cell recovery from liquid nitrogen
Cryovials were removed from liquid nitrogen and thawed quickly at 37°C. The 
cells were resuspended in culture medium and centrifuged at 80g for 5min, so 
as to remove the DMSO present. The cell pellet was then resuspended in 
proliferation medium (Table 2.2) for plating prior to culture in a humified 
tissue-culture incubator (Jencons Nuair, Leighton Buzzard, UK) at 37°C and 
5% (v/v) CO2 . Aseptic technique was used throughout this and the following 
three procedures.
2.3.8 Proliferation of cells on plastic
Cells were plated aseptically onto 6-well culture plates at a density of 1 x 105 
cells/cm and allowed to proliferate till they were about 90% confluent, 
determined using phase-contrast microscope, before passaging. Medium was 
changed every two days.
2.3.9 Passaging cells
Medium was removed from the wells and the cells were washed twice with 
2ml of HBSS. To each well, 0.6ml of sterile trypsin solution containing EGTA 
(0.4mg/ml) and polyvinyl alcohol (O.lmg/ml), was added to the cells. The 
cells were incubated in the trypsin solution for at least 40min before sterile 
serum-containing medium was added to neutralise trypsin’s activity. Cells 
were pelleted (80 g, 5min) and resuspended in the appropriate culture medium 
aseptically for plating on either plastic or EHS matrix.
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Table 2.2 Composition of media used in the culture of caprine mammary
epithelial cells
Proliferation 
(on plastic)
Attachment 
(on EHS matrix)
Differentiation 
(on EHS matrix)
Basal medium
Medium 199 lx lx lx
Hams F12 lx lx lx
Hepes buffer (mM) 10 10 10
NaHC03 (mM) 27 27 27
Sodium acetate (mM) 2 2 2
Penicillin (U/ml) 200 200 200
Streptomycin (pg/ml) 200 200 200
Fungizone (pg/ml) 2.5 2.5 2.5
EGF1 (ng/ml) 10 - -
Insulin (pg/ml) 5 5 5
Cortisol (pg/ml) 1 1 1
Prolactin2 (pg/ml)
- 3 3
Horse serum (%)
20 20 -
Foetal calf serum (%)
5 5
!EGF was prepared by dissolving lOOpg in 10ml of 0.9% (w/v) saline 
2Prolactin was prepared by dissolving lOmg in 2.5ml of lOmM Hepes (pH 8.0) 
and diluting to 0.1 mg/ml with water.
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2.3.10 Differentiation of cells on EHS matrix
EHS matrix was thawed on ice and applied to ice-cold tissue culture plates 
(50pl/cm2). The matrix was then allowed to polymerise at RT for 30min. Cells 
were plated gently in attachment medium (Table 2.2) at a density of 3 x 
105/cm2. After 24h, attachment medium was replaced with serum-free 
differentiation medium (Table 2.2), allowing the mammary epithelial cell 
clumps to differentiate and form mammospheres. The medium was changed 
daily.
2.4 CULTURE OF MOUSE MAMMARY EPITHELIAL CELLS
Similarly, mammary tissue was collected from mid-pregnant mice and 
processed to yield mammary epithelial cell clumps, which when differentiated 
on EHS matrix, formed mammospheres.
2.4.1 Cell Culture media
Basal media (pH7.4) was prepared and stored at 4°C. All enzymes and 
hormones were added to the basal medium on the day of use. Table 2.3 gives a 
summary of the cell culture media used in the isolation of mouse mammary 
epithelial cells.
2.4.2 Preparation of mammary epithelial cells
Pregnant mice (dl5-17) were sacrificed by cervical dislocation and both the 
inguinal glands were removed. Aseptic techinques was used from this point 
on. The mammary tissue was incubated in HBSS (pH 7.4, 37°C) and then 
finely chopped to aid digestion. The finely minced tissue was then transferred 
to the digestion medium (Table 2.3), and incubated at 37°C in a orbital 
incubator shaking at 120 rpm for 90min. The digest mixture was then filtered 
through a 150pm pore nylon mesh and the cells were harvested by
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centrifugation (80 g, 5min). The cell pellet was resuspended in wash medium 
(Table 2.3) and re-harvested. The cells were subjected to three more washes 
before being filtered through a 50pm nylon mesh. The cells were harvested as 
before and resuspended in culture medium (Table 2.4). They were cultured for 
lh at 37°C to allow fibroblast attachment. The non-adherent mammary 
epithelial cells were recovered and the cell yield was estimated as described in 
section 2.3.4.
2.4.3 Differentiation of cells on EHS matrix
EHS was applied to the tissue culture plates as described in section 2.3.9. Cells
c o
were plated at a density of 3 xlO /cm and allowed to attach for 24hr in 
attachment medium (Table2.4) before transferring to a serum-free 
differentiation medium (Table 2.4). The differentiation medium was 
replenished daily.
2.5 MEASUREMENT OF PROTEIN SYNTHESIS AND 
SECRETION
Protein synthesis and secretion in the caprine and mouse mammospheres were 
analysed using a radio-labelled precursor of protein synthesis.
2.5.1 Radio-labelling of synthesised proteins
The mammospheres were incubated in fresh differentiation medium, 
containing 30pCi/ml of 35S-Methionine, for 24hr. The culture medium, 
luminal secretion and cells were collected for assay of [35S]-labelled protein.
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Table 2.3 Composition of media used in isolation of mouse mammary
epithelial cells
Wash Medium Digestion medium
Basal medium
HBSS lx lx
MEAA lx lx
D-glucose (mM) 5 5
Bovine serum albumin (mg/ml) - 40
Calcium Chloride (ug/ml) 2.5 2.5
Magnesium Sulphate (ug/ml) 2.2 2.2
Hepes (mM) 5.7 -
Glutamine (mM) 2 2
Fungizone (ug/ml) 2.5 2.5
Penicillin (ug/ml) 120 120
Kanamycin (ug/ml) 100 100
Hormones
Insulin (ug/ml) 5 5
Cortisol (ug/ml) 1 1
Enzymes
Collagenase1 (mg/ml) 1.2
Dnase I (ug/ml) 20 -
Trypsin inhibitor (ug/ml) 100 -
!Type 3, ~ 150u/mg
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Table 2.4 Composition of media used in the culture of mouse mammary
epithelial cells
Attachment 
(on EHS matrix)
Differentiation 
(on EHS matrix)
Basal medium
Medium 199 lx lx
Hams F I2 lx lx
Sodium Bicarbonate (mM) 70 70
Hepes (mM) 20 20
Penicillin (U/ml) 120 120
Kanamycin (ug/ml) 100 100
Supplements
Insulin (ug/ml) 5 5
Cortisol (ug/ml) 1 1
Prolactin (ug/ml) 3 3
Triiodothyronine (ng/ml) 0.65 0.65
Glucose (mM) 1 1
Hepes (mM) 1.5 2.5
Foetal calf serum (%) 10 -
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2.5.2 Harvesting of secreted proteins and cells
The culture medium was removed from the cells and kept. To harvest the 
luminal proteins, cells were first rinsed in HBSS pH7.4 containing lOmM 
Hepes, followed by incubating in HBSS pH7.4 containing lOmM Hepes and 
2.5mM EGTA, for 20min at 37°C. To detach the cells from the EHS matrix, 
they were treated with Dispase (Universal Biologicals Ltd, London, UK) and 
recovered by centrifugation (13,000g, lmin, 4°C). All samples collected were 
snap frozen in liquid nitrogen and stored at -20°C.
2.5.3 Precipitation of proteins
To all medium and luminal extracts, 0.01% (w/v) BSA was added. The cell 
pellets were sonicated (15s at setting 30; Kontes micro-ultrasonic cell 
disruptor, Burkard Scientific, Rickmansworth, UK) in 400pl of DNA assay 
buffer (Section 2.7), and then lOOpl of the homogenate was used for 
precipitation. To all samples, an equal volume of ice-cold 20% (w/v) 
trichloroacetic acid was added and incubated on ice for 30min before being 
subjected to centrifugation (12,000 rpm, 5min, 4°C). The precipitated protein 
was washed twice in 1% (w/v) trichloroacetic acid (12,000 rpm, 4min) and 
dissolved in lOOpl of 1M Tris-HCl (pH 7.6). Protein sample was transferred to 
a scintillation vial, containing 10ml of scintillation fluid, and [ S] activity was 
determined.
2.5.4 Protein samples for gel electrophoresis
The remaining protein samples from culture medium and luminal extracts 
were re-precipitated as described in section 2.5.3, and after the final wash, the 
pellet was dissolved in 25pl of 50mM Tris-HCl (pH7.6). Samples were 
analysed based on an equal DNA concentration so appropriate volume of
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samples were dissolved in NuPAGE® LDS sample buffer (Invitrogen, 
Groningen, The Netherlands). On the actual day of use, 0.1% (v/v) P- 
mercaptoethanol was added to the samples and heated at 70°C for lOmin.
2.5.5 SDS-PAGE
Proteins were resolved by electrophoresis (Laemmli,1970) using the Xcell 
SureLock™ Mini-Cell kit (Invitrogen, Groningen, The Netherlands). 
Standards and samples were separated on NuPAGE® 12% Bis-Tris gel 
(Invitrogen) at 200 v for 45min in NuPAGE® MES SDS running buffer 
(Invitrogen, Groningen).
2.5.6 Staining and fixing of gels
The gel was first washed in deionised water (3 x 5min) before being stained 
with SimplyBlue™ Safestain (Invitrogen, Groningen, The Netherlands) for lh. 
After staining, the gel was immersed in deionised water overnight. The gel 
was then fixed (50% (v/v) methanol ; 10% (v/v) acetic acid) for 15min and 
rinsed (7% methanol; 7% acetic acid and 1% glycerol) for lOmin. Finally it 
was dried onto filter paper on a gel dryer (Bio-Rad Laboratories Ltd, Herts, 
UK) at 80°C for lh using cycle 1.
2.5.7 Autoradiography
Gels were exposed to a phosphor-screen cassette for 4 days before being 
quantified using a Phosphoimager™ 445SI (Molecular Dynamics, Sunnyvale 
CA, USA).
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2.5.8 Western blotting and ECL
Proteins were transferred (100 v, 90min) to PVDF membrane (Immobilon P, 
Millipore, Watford, UK) in NuPAGE® Transfer Buffer. The membrane was 
immediately blocked overnight by incubating in PBS containing 3% (w/v) 
BSA, 1% (v/v) fish gelatin and 0.05% (v/v) NP40 at pH 7.4. Antibodies were 
diluted in PBS containing 0.3% (w/v) BSA, 0.1% (v/v) fish gelatin and 0.05% 
(v/v) NP40, which also served as a wash buffer. The membrane was incubated 
with sheep anti-bovine casein (1:7000) or rabbit anti-bovine P-lactoglobulin 
(1:3500) for lh and then washed three times for 15min in wash buffer. 
Biotinylated anti-sheep IgG (Vector Laboratories Inc., USA), diluted 1:5000, 
or anti-rabbit IgG (Amersham Pharmacia Biotech, Little Chalfont, UK), 
diluted 1:5000, was added to the membrane for lh  followed by washes as 
before. The membrane was incubated with avidin-biotin complex for 45min. 
Detection of protein bands was achieved by incubating the membrane with 
enhanced chemiluminescent reagent (Renaissance; NEN Dupont, Stevenage, 
UK) and exposing the membrane to x-ray film (Fuji RX) for 10 -  30s. 
Densitometry of blots was carried out using ImageQuant (Molecular 
Dynamics, Sunnyvale CA, USA).
2.6 PROTEIN ASSAY
Protein content was measured spectrophotometrically as described by 
(Bradford, 1976), using BSA as the protein standard (0.03mg/ml). Standards 
were prepared in the range of 0 - 3ug. Both standards and samples were made 
up to 200pl before the addition of 140pl of threefold diluted Bradford reagent 
(Bio-rad Laboratories Ltd, Hempstead,UK). Coloured complex formation was
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determined at a wavelength of 595nm using a Titertek multiskan plate reader 
(Labsystems Ltd., Basingstoke, UK).
2.7 PHOTOGRAPHY
Brightfield, phase contrast and fluorescence colour photographs were taken 
using Fujicrome Provia 400 or Fujichrome colour 64T 64 ASA tungsten film 
on a Leitz DMR microscope (Leica, Nussloch, Germany).
2.8 STATISTICS
Data was compared by ANOVA using Genstat 5 (Release 4.1, Lawes 
Agricultural Trust, Rothamsted Experimental Station, Herts, UK) or Minitab 
(Release 11, Minitab Inc, State College, PA 16801, USA). The data from 
chapter 3 was first transformed using angular transformation and then 
analysed by Tukey’s pairwise comparison while in Chapter 5, the data was 
normalized by log transformation.
55
CHAPTER THREE 
PROLIFERATION AND APOPTOSIS IN MOUSE MAMMARY
GLAND
3.1 INTRODUCTION
The mammary gland displays distinct morphological differences at various 
stages of development. The gland is composed mainly of adipocytes before 
puberty, while during pregnancy, the adipocytes are gradually displaced to 
allow development in preparation for lactation. At lactogensis, the adipocytes 
have virtually disappeared leaving secretory alveoli responsible for milk 
production. From this observation, we can see that the ratio of mammary 
epithelial cell to adipocytes, and possibly their interactions, changes 
depending on the stage of development.
Cell proliferation and apoptosis are two physiologically essential 
processes in normal mammary gland development and function. It is well 
established that proliferation in the mammary gland occurs mainly during the 
onset of puberty and especially during pregnancy while during weaning, 
apoptosis plays a central role in the remodelling of the gland. Throughout the 
years, studies have either examined proliferation (Korfsmeier,1979) or 
apoptosis (Strange et al.,2001) separately. Laboratories have measured 
mammary cell proliferation during pregnancy and lactation (Knight and
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Peaker,1982), using measurement of DNA content and incorporation of [ H]- 
thymidine in vitro as a marker. Humphreys et al.(1996) demonstrated that in 
addition to its role during involution, apoptosis also occurs in TEB during 
ductal morphogenesis. With the exception of Capuco et al.(2001), where both 
proliferation and apoptosis during a bovine lactation was investigated, to date
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no other study has ever simultaneously quantified proliferation and apoptosis 
during the whole of mammary gland development.
Inappropriate development in the mammary gland can have long term 
repercussions. Pre-pubertal heifers fed on high plane diets have less ductular 
outgrowth and reduced milk yield (Sejrsen and Purup,1997). Besides that, 
reproductive histories have also been demonstrated to influence mammary 
development in humans. Women with a lactational history are less prone to 
developing breast lesions. This beneficial effect of reproductive history has 
been suggested to be exerted through the control of mammary epithelial cell 
proliferation (Peris and Knight, 1997).
The aims of the studies reported in this chapter were:
1. To examine mammary cell proliferation and apoptosis in the murine 
mammary gland at various stages of development using 
immunohistochemistry.
2. To determine if lactational history has a long-term effect on 
proliferation and apoptosis of mammary epithelial cells.
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3.2 EXPERIMENTAL DESIGN
3.2.1 Comparison of proliferation and apoptosis during different stages 
of development
Mammary proliferation and apoptosis were measured in groups of 6 
contemporaneous mice at various stages of development. Virgin mice were 
studied at 4wks, 8wks, 12wks and 24wks old, all measurements being made at 
oestrous, determined through virginal smears. Pregnant mice were sampled at 
dl, d6, dl2 and dl8 of pregnancy, which was established at 8wks of age. 
Lactating mice were studied at d l, d7, dl4, d21 and d28, pups being left with 
the mothers throughout. For comparison with standard first lactation mice, an 
additional group was studied on dl of a second lactation. Cell proliferation 
was detected by incorporation of bromodeoxyuridine (BrdU) in vivo. This was 
achieved by administrating 5 s.c. injections each of 150pg given at 1400 and 
2000hr on the first day (pro-oestrus in virgins, determined from daily cervical 
smear, while in pregnant and lactating groups, 1 day before actual 
measurement i.e. day 5 for day 6 pregnant group) and at 0800, 1400 and 
2000hr on the following day. Mice were sacrificed at lOOOhr the next day and 
the fourth pair of mammary glands were removed. One of the glands was 
mounted onto slides for wholemount image analysis while the remaining gland 
was embedded in wax and later sectioned to measure proliferation and 
apoptosis. Procedures for detecting and counting proliferating and apoptotic 
cells were described in Chapter 2.
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3.2.2 Effect of lactational history on mammary epithelial cell
proliferation and apoptosis
Mammary cell proliferation and apoptosis were measured in 4 groups 
of contemporaneous mice at 24wks of age. The four treatment groups were: 
virgin (V); previously pregnant with no lactation (P); previously lactated (L) 
and previously unilaterally lactated (UL). For the last group, all 5 mammary 
glands on the right side of the mouse were teat-sealed using skin adhesive so 
as to prevent lactation. Adhesive was applied under general anaesthesia and 
then was checked twice daily and replaced when necessary. Litter size was 
adjusted to 5 pups for this group. Pregnancy commenced at 8 weeks of age. 
The four groups of mice were then left until 24wks of age before BrdU was 
administered at oestrous as described in section 3.2.1. The fourth mammary 
glands were removed as before for histological analysis.
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3.3 RESULTS
3.3.1 Histological analysis of mouse mammary glands
Wholemount analysis of the mouse mammary gland was carried out at 
different stages of development. Figures 3.1 & 3.2 show examples of the 
mammary gland at the virgin stage. A simple branching network of mammary 
ducts is seen at 4wks of age (Figure 3.1 A). The rudimentary ductal system 
originating from the nipple (N) is seen growing towards the lymph node (LN). 
Figure 3.IE at a higher magnification (168x) shows a primary ductal branch 
consisting of terminal end buds (TEBs). After puberty (Figure 3.IB), the fat 
pad in the mammary gland becomes completely infiltrated with the epithelial 
branching network. In addition, the formation of lower-order ducts and 
bifurcation of end buds has also started appearing (Figure 3.IF). At 12 & 
24wks old (Figures 3.1C & D), the epithelial network has become more dense 
and the terminal end buds are more complex forming lobular structures 
(Figures 3.1G & H).
Figure 3.2 shows sections of the virgin mammary gland embedded in 
wax. In Figures 3.2A & B, which show the gland at 4wks old, we see the ducts 
and TEBs, stained blue, in cross-sections. At this stage, the mammary gland is 
still predominantly composed of adipocytes. As the gland matures, we see the 
formation of lobular structures (Figures 3.2C & D) and there is an indication 
that the ratio of epithelial cells to adipocytes is getting higher (Figure 3.1C & 
E). However, looking at the sections of aged mice (Figure 3.2F), there seem to 
be a lower ratio of epithelial cells to adipocytes when compared to early stages 
(Figures 3.2C & E).
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Figure 3.1 Wholemounts of virgin mouse mammary glands
Mammary glands from virgin mice were fixed and stained with carmine. A & 
E) 4wks old , B & F) 8wks old , C & G) 12wks old and D & H) 24wks old. 
Bar = 2mm (A, B, C & D) and Bar = 71.42pm (E, F & G at Magnification 
168x). LN: Lymph node, BV: Blood vessel and N: Nipple.
61
AC
E
v
■» ' % •>. a |  ^  ■' & 
* * * * *  ,■  -
: 2^ - * -
Figure 3.2 Wax-embedded sections of virgin mouse mammary gland
Mouse mammary glands were embedded in wax and sectioned at 4|am. A & 
B) 4wks old, C&D) 8wks old, E) 12wks old and F) 24wks old. A,C,E & F 
were taken at 420x magnification while B & D were at magnification 1680x
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During pregnancy, the mammary gland at days 1 & 6 showed similar patterns 
of growth (Figures 3.3A & B). The ductal systems were growing towards the 
extreme end of the fat pad. Sections of the gland during these two periods 
showed that most of the gland was still predominantly occupied by the 
adipocytes (Figures 3.4A & B). This pattern of growth was not observed at 
day 12 of pregnancy; instead we observed an increase in complexity of the 
ductal system. In addition to occupying the fat pad (Figure 3.3C), there was 
also the formation of dense grape-like structures called alveoli (Figure 3.3D & 
E). Cross-sections of the gland at this stage, showed that it was no longer 
occupied predominantly by adipocytes, instead there were clusters of lobulo- 
alveolar structures (Figure 3.4C & D). By day 18 of pregnancy (Figure 3.3F), 
the whole gland was completely filled with alveoli-like structures. Histological 
sections of the gland at this stage showed that it is almost completely occupied 
by the alveoli (Figure 3.4E) which are secreting lipids and milk-like 
components (Figure 3.4F).
During lactation, the mammary gland is completely filled with lobulo- 
alveolar structures (Figure 3.5A-E). Sections confirmed that the mammary 
gland was composed almost entirely of milk-secreting alveoli [Figure 3.6a]. 
Adipocytes in the gland were no longer evident. Interestingly, at day 7 of 
lactation [Figure 3.6a (C&D)], the size of alveoli seems to be bigger compared 
to those during the onset of lactation [Figure 3.6a (A&B)]. At day 14 of 
lactation [Figure 3.6a (E&F)], there is an indication of the collapsing of the 
alveoli since the integrity of its structure has been reduced. By day 21, the 
gland has started to revert to that of the virgin stage [Figure 3.6b (A&B)]. 
Besides milk-secreting alveoli, mammary epithelial cells and adipocytes were
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also observed. Wholemounts [Figure 3.5a (F)] and sections [Figure 3.6b 
(C&D)] at day 28, displayed a gland that has reverted back to a state similar to 
that of virgin mice. Adipocytes are once more the dominant feature.
The appearance of the gland was similar at the start of the second 
lactation compared to the first, although there did appear to be more 
adipocytes and, perhaps, larger alveoli (Figure 3.7).
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BD
Figure 3.3 Wholemounts of pregnant mouse mammary gland
Mammary glands from pregnant mice were fixed and stained with carmine.
A) day 1, B) day 6, C-E) day 12 and F) day 18. Bar = 2mm ( A ,B ?C  & F) 
while Bar = 71.2pm for D and E at magnification 168x and 420x 
respectively.
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Figure 3.4 Wax-embedded sections of pregnant mice mammary gland
Mammary glands were embedded in wax and sectioned at 4|im. A) dayl, B) 
day 6, C & D) day 12 and E&F) day 18. A, B, C, & E at magnification 420x 
while D & F were taken at magnification 1680x. Bar = 71.42jam
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Figure 3.5 Wholemounts of mammary glands taken from lactating mice
Mammary glands from lactating mice were fixed and stained with carmine. 
A & B )  day 1 , C) day 7, D) day 14, E) day 21 and F) day 28. Bar = 2mm (A, 
C, D, E & F) while B was taken at magnification 420x and Bar = 71.42|am.
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Figure 3.6a Wax-embedded sections of the lactating mouse mammary 
gland
Mammary glands were embedded in wax and sectioned at 4(am. A & B )  day 1, 
C & D) day 7 and E & F) day 14. A, C & D at magnification 420x while B, E 
& F at magnification 1680x. Bar = 71.42(im
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Figure 3.6b Wax-embedded sections of the lactating mouse mammary 
gland
Mammary glands were embedded in wax and sectioned at 4jam. A & B )  day 
21 and C & D) day 28. A & C at magnification 420x and B & D at 
magnification 1680x. Bar = 71.42jam.
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Figure 3.7 Comparison of 2nd lactation in mouse mammary glands
Mammary glands were embedded in wax and section at 4pm. A) 1s 1 lactation 
day 1 and B) 2nd lactation day 1. Magnification 1680x, Bar = 71.42pm.
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3.3.2 Mammary epithelial cell proliferation and apoptosis during
different stages of development
Figure 3.8 shows examples of proliferation and apoptosis at different 
stages of development. Since the two methodologies utilise the same detection 
system (DAB) proliferating and apoptotic cells both appear as brown-stained 
nuclei in the respective sections. Simple visual inspection shows that at day 6 
of pregnancy, more proliferation (Figure 3.8A) was detected as compared to 
apoptosis (Figure 3.8B). On the other hand, at day 21 of lactation more 
apoptosis was detected instead (Figure 3.8D) then was proliferation (Figure 
3.8C).
Proliferation and apoptosis were quantified in virgin, pregnant and 
lactating mice. Statistical analysis of the data is reported in Tables 3.1, 3.2 and 
3.3, data is presented graphically in Figures 3.9 to 3.11. Data for virgin mice 
are in Figure 3.9. At 4wks old there seems to be more proliferation when 
compared to the other stages, however, this difference was not statistically 
significant (P>0.05). None of the virgin groups differed significantly in 
proliferation. Apoptosis, on the other hand, was higher at 4wks, 8wks and 
12wks when compared to 24wks old, a difference that was statistically 
significant (P<0.05). The apparent increase from 4wks to 12wks was not 
statistically significant.When both processes were compared, there was more 
apoptosis than proliferation at 4wks, 8wks and 12wks old virgin mice 
(P<0.01), but not at 24wks (Table 3.3).
No proliferation could be detected on day 1 of pregnancy, but by day 6 
approximately 10% of epithelial cells were proliferating (Figure 3.10). Values 
at day 6, 12 and 18 were significantly higher compared to day 1 (P<0.05). The
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peak value was reached at day 12, higher than both day 6 (non-significantly) 
and day 18 (P< 0.01, Table 3.1) Apoptosis was detected in all stages of 
pregnancy and there was no significant difference between them (P>0.05). At 
day 6 and 12 of pregnancy, there was significantly more proliferation than 
apoptosis (PO.Ol, Table 3.3). This was not the case at the end of the 
pregnancy.
Mammary epithelial cell proliferation was detected at modest levels 
throughout lactation (Figure 3.11) and did not differ significantly between 
days (P>0.05, Table 3.1). Proliferation on day 1 of a second lactation was not 
significantly different (P>0.05) from the same stage of the first lactation. 
Apoptosis was also detected throughout lactation. At day 1 of lactation there 
was more apoptosis detected compared to days 7, 14 and 21, however this was 
not statistically significant. At day 28 of lactation, there was significantly 
more apoptosis (PO.Ol) compared to earlier stages of lactation (Table 3.2). 
Apoptosis on day 1 of a second lactation was not significantly different 
(P>0.05) from the same stage of the first lactation. At day 28 of lactation and 
day 1 of a second lactation, but not the other stages, there was more apoptosis 
occurring than proliferation (PO.Ol, Table 3.3).
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Figure 3.8 Mammary proliferation and apoptosis at different stages of 
development
Figures A & B  shows sections of the mouse mammary gland at day 6 
pregnancy while Figures C & D shows sections of the gland at day 21 of 
lactation. At day 6 of pregnancy, there is more proliferation (A) as compared 
to apoptosis (B). In contrary, more apoptosis (D) is detected during day 21 of 
lactation than proliferation (C). Figures A & B  were taken at magnification 
1680x while Figures C & D were at magnification 420x. Bar = 71.42pm
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Figure 3.9 Mammary epithelial cell apoptosis and proliferation in virgin 
mice
Mammary epithelial cell proliferation and apoptosis were compared at various 
time points in virgin mice. Values are the mean ± SE for 6 animals and 
expressed as a percentage of positive over total cells counted. At 4, 8 & 
12wks, there were more apoptosis as compared to proliferation in the virgin 
mammary gland (P< 0.01)
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Figure 3.10 Mammary epithelial cell apoptosis and proliferation in 
pregnant mice
Mammary epithelial cell proliferation and apoptosis were compared at various 
time points in pregnant mice. Values are the mean ± SE for 6 animals and 
expressed as a percentage of positive over total cells counted. At day 6 & 12 
of pregnancy, there was an increase in proliferation compared to apoptosis (P< 
0.01).
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Figure 3.11 Mammary epithelial cell apoptosis and proliferation in 
lactating mice
Mammary epithelial cell proliferation and apoptosis were compared at various 
time points in lactating mice. Values are the mean ± SE for 6 animals and 
expressed as a percentage of positive over total cells counted. At day 28 and 
2nd lactation day 1, there was more apoptosis compared to proliferation 
(PO.Ol).
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Stage of development
Ratio of proliferation to 
apoptosis P-value
Virgin 4wks 0.42 <0.01
Virgin 8wks 0.12 <0.01
Virgin 12wks 0.13 <0.01
Virgin 24wks 1.33 0.37
Pregnant Dl 0.00 <0.05
Pregnant D6 27.41 <0.01
Pregnant D12 37.09 <0.01
Pregnant D18 1.62 0.06
Lactation Dl 0.69 0.47
Lactation D7 0.53 0.38
Lactation D14 0.54 0.59
Lactation D21 1.59 0.36
Lactation D28 0.09 <0.01
2nd Lactaction dl 0.52 0.01
Table 3.3 Comparison between proliferation and apoptosis within 
each developmental group in the mouse mammary gland.
Data from virgin (V), pregnant (P) and lactating (L) groups were angular 
transformed and the p-values were generated using post-hoc test.
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3.3.3 Effect of lactational history on mammary epithelial cell proliferation 
and apoptosis
Cell proliferation and apoptosis were measured at estrous in aged mice of 
differing reproductive histories. Proliferation of mammary epithelial cells in mice 
that have previously lactated (Figure 3.12), was significantly lower compared to 
virgins (PO.Ol). On the other hand, in mice that had gestational but not 
lactational history, proliferation was reduced marginally (P= 0.056). Between ex­
pregnant and ex-lactated groups, there was no significant difference in mammary 
epithelial cell proliferation (P> 0.05). The effect of lactational history on 
mammary epithelial cell proliferation was further demonstrated in Figure 3.15. 
Within mice, when one side of the gland was prevented from lactating, this gland 
was shown to have more proliferation occurring when compared with the gland 
that was allowed to lactate (P<0.01).
Apoptosis data for mice of different reproductive histories is shown in 
Figures 3.13-3.15. A significant difference was detected between groups (P< 0.05, 
Figure 3.13). Apoptosis was significantly reduced by a previous pregnancy (P< 
0.05, Figure 3.13) but this was partially reversed in mice which had then gone on 
to lactate normally. However, the unilateral lactation model did not detect any 
difference between individuals glands which had been suckled or not (Figure 
3.15). When apoptosis, between the two individual fourth glands was compared 
within animal apoptosis in the left gland of virgins and ex-pregnant groups was 
significantly higher than in the right gland (P< 0.01, Figure 3.14).
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Virgin Ex-pregnant Ex-lactated
Figure 3.12 Mammary epithelial cell proliferation in mice of different 
reproductive histories.
Mammary epithelial cell proliferation was measured at oestrous in virgin, 
ex-pregnant and ex-lactating mice using BrdU incorporation. Values are 
the mean ± SD for 6 animals and are expressed as a percentage of positive 
over total cells counted. Data with different superscripts differ 
significantly (P< 0.01). * denotes p= 0.056 when compared with virgin 
group.
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Figure 3.13 Mammary epithelial cell apoptosis in mice of different 
reproductive histories
Mammary epithelial cell apoptosis was measured at oestrous in virgin, ex­
pregnant and ex-lactating mice. Values are mean ± SD for 6 animals and 
are expressed as a percentage of positive over total cells counted. Data 
with different superscripts differ significantly (P< 0.05)
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Virgin Ex-pregnant Ex-lactate d
Figure 3.14 Mammary epithelial apoptosis in the left and right 
inguinal glands of mice with different reproductive histories
Mammary epithelial apoptosis was investigated in mice of different 
reproductive histories. Values are the mean ± SD from both fourth glands 
within each group for 6 animals and are expressed as a percentage of 
positive over total cells counted. Data with different superscripts differ 
significantly (P< 0.01).
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Figure 3.15 Effect of unilateral suckling on mammary epithelial cell 
proliferation and apoptosis
The effect of unilateral suckling on mammary epithelial cell proliferation 
and apoptosis. Values are the mean ± SD for 6 animals and are expressed 
as a percentage of positive over total cells counted. Data with different 
superscripts differ significantly (P< 0.01)
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3.4 DISCUSSION
Wholemount analysis and histological studies carried out in Section 3.3.1 
provided a detailed picture of mammary development in the mouse. Development 
of the gland in prepubertal mice is rudimentary. At this stage, adipocytes are the 
predominant cell type in the gland. With the onset of puberty, the ductal 
branching network infiltrates the fat pad. These observations are consistent with 
previous studies (Richert et al.,2000). As the mouse ages, this ductal system 
becomes more dense and complex. At 24wks old (Figure 3.1H), these mice 
displayed alveoli-like structures containing a hollow centre resembling the alveoli 
during lactation. Such structures have also been previously demonstrated (Richert 
et al.,2000; Schedin et al.,2000) and have been attributed to the cyclic secretion of 
ovarian hormones during the estrous cycle (Andres and Strange, 1999).
During pregnancy, mammary epithelial cell number increases as a 
consequence of increased proliferation. At day 12 (Figure 3.4 C&D), alveolar 
structures have appeared and the size of these alveoli increases as the animal 
approaches parturition (Figure 3.4 E&F). In fact, from early pregnancy to day 18 
of lactation, there is a 21-fold increase in cell volume (Foster, 1977). During 
lactation, this increase in cell volume is due to the hypertrophy of secretory 
alveolar cells [Figure 3.6a (B&D)]. The onset of lactogenesis is associated with an 
increase in amounts of milk specific products such as lactose, caseins, a- 
lactalbumin and p-lactoglobulin (in mice), hence the hypertrophy during early 
lactation. On the other hand, during established lactation, hypertrophy [Figure 
3.6a (D)] in these secretory alveolar cells could be the consequence of milk
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accumulation. The rate of milk secretion gradually increases post-partum which 
leads to more milk in the lumen and hence hypertrophy of secretory alveolar cells.
Sections obtained from the lactating gland (dayl) in a second lactation 
(Figure 3.7), demonstrated the presence of adipocytes which were previously 
absent during the first lactation (dayl). The observation of adipocytes during early 
lactation has previously been reported (Richert et al.,2000). That study showed 
that at day 2 of lactation, 30% of the mammary gland was still filled with 
adipocytes.
Besides observing adipocytes during early lactation, under the same 
magnification, in addition to less alveoli present, the alveolar size on day 1 of a 
second lactation seems to be bigger than those observed on day 1 during a first 
lactation (Figure 3.7). Does this mean a higher capacity to cope with expected 
demand thus a reduction in alveoli number during a subsequent lactation? This 
remains plausible since it has been shown that as lactation becomes more 
established, the adipocytes would be displaced completely to allow expansion of 
alveoli to fill the gland (Richert et al.,2000). This is further supported by the fact 
that proliferation still occurs in early lactation (Knight and Peaker,1982; 
Tucker, 1987).
One of the original objectives had been to accurately quantify the relative 
proportions of stromal adipose tissue and epithelial parenchymal tissue at 
different stages of development. The intimate association of mammary epithelial 
cells with adipocytes has been discussed in Chapter one, however no study to date 
has actually quantified the relative proportions and distributions of adipose and
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alveolar tissue. By doing so, we hoped to provide insight about the relationship 
between the two cell types in the mammary gland.
Manual quantification of specific features within histological sections is 
time-consuming and labour-intensive. However, image-analysis techniques, 
which allow quantification and classification of images and objects of interest 
within images, are available to generate accurate data rapidly. Image-analysis 
algorithms suitable for mammary tissue are being developed as part of a 
collaboration between our laboratory, Biological Statistics Scotland and 
Strathclyde University. Because this work is ongoing it was decided not to 
proceed with quantitative analysis of parenchymal and stromal areas, pending 
availability of the new technique.
In order to ensure normal development of the mammary gland, a balance 
between proliferation and apoptosis is required. Most studies have only focused 
on apoptosis during involution; nonetheless, detecting apoptosis in virgin mice is 
not unusual (Strange et al.,2001). Cap cells, which form the outermost layer of the 
end bud, have been demonstrated to have the highest rate of proliferation and 
concurrently body cells, which fill the interior of the end bud, are undergoing 
apoptosis so as to form the lumen of the duct (Richert et al.,2000). Apoptosis and 
tissue remodelling are thus essential to prepare the gland morphologically for 
future roles such as formation of more complex and differentiated structures.
Hence, the second objective of this chapter was to measure both 
proliferation and apoptosis simultaneously in the mouse mammary gland at 
different stages of development. Both proliferation and apoptosis were detected in
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the virgin mice at all stages examined (Figure 3.9). Proliferation, in the presence 
of ovarian hormones, was highest at 4wks old, when compared to 8, 12 and 
24wks old, even though it was not statistically significant (P>0.05). This 
observation is consistent with previous studies (Sinha and Tucker, 1966; 
Korfsmeier,1979). Since highest proliferation is detected during that stage, this 
would also explain why we see a decrease in mammary epithelial cell 
proliferation at 8wks old (Figure 3.9). At 12wks and 24wks old, there was no 
significant difference in the rate of proliferation. Proliferation of mammary 
epithelial cells detected at these stages is probably involved in the establishment 
of secondary and tertiary structures in the mammary gland.
Unlike proliferation, apoptosis in virgin mice increased with age up to 
12wks old. As the mice aged further (24wks old), apoptosis occurring in the 
virgin gland had decreased significantly. Why apoptosis increases earlier in life 
and then decreases as the animal ages remains to be determined.
When both apoptosis and proliferation were compared in these mice, we 
can see that at 4, 8 and 12 wks old, there was a higher rate of apoptosis occurring 
in the gland. This is an interesting observation as one would expect proliferation 
rather than apoptosis to be the predominant process occurring in the virgin gland. 
Proliferation and apoptosis in these virgin mice were measured at 
proestrous/estrous and estrous respectively. Schedin et al.(2000) demonstrated 
that in cycling rats, the highest proliferative index was achieved between 
metestrus and diestrus-1. If this is also true in mice, that could explain why there 
was lower proliferation detected compared to apoptosis. Schedin et al.(2000) also
showed that, even though there was no significant difference between the stages 
in estrous cycle, at estrous, apoptosis was at one of it’s highest (~ 7%). This could 
be why a higher rate of apoptosis was detected in the present study.
We have raised the possibility that the stage of estrous cycle could have 
contributed to the low proliferation and high apoptosis detected in our study. 
Nonetheless, other factors might be involved as well. One possible consideration 
is the methodology that was employed for the detection of apoptosis. Apoptosis 
was detected through terminal deoxyribonucleotidyl transferase (TDT)-mediated 
dUTP-digoxigenin nick end labelling (TUNEL) assay. However, the fidelity of 
this assay is in doubt since in some analyses it failed to fully discriminate between 
apoptosis and necrosis (Grasl-Kraupp et al.,1995; Frankfurt et al.,1996). To 
eradicate this doubt, a sensible precaution would be to complement TUNEL assay 
with other specific markers of apoptosis such as DNA-laddering or caspase 
activation.
During pregnancy and lactation (Figures 3.10 & 3.11), proliferation of 
mammary epithelial cells was highest at day 12 of pregnancy. This observation is 
consistent with Knight and Peaker (1982). who showed that incorporation of 3H- 
thymidine into mammary tissue was highest on day 12 of pregnancy. They also 
showed that after day 12, there was a decrease in proliferation followed by a 
second peak at day 2 of lactation. This is again rather similar to our observation, 
with the exception that our data did not indicate a higher peak at day 1 of 
lactation. Apoptosis was highest at day 18 of pregnancy and since peak mammary 
differentiation occurs during day 19-21 of pregnancy (Nandi, 1958), some cell
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death might have to occur to allow the formation of alveolar cells. Studies have 
shown that formation of ducts in the early developing mammary gland involves 
selective death of a population of terminal end bud epithelial cells (Humphreys et 
al., 1996). The same process might also be involved during peak mammary 
differentiation. From day 7 to day 21 of lactation (Figure 3.11), minimal cell 
turnover was detected. The huge increase in apoptosis at day 28 of lactation 
(P<0.01) is due to involution of the gland (Lund et al.,1996; Strange et al.,2001). 
Mammary apoptosis has been studied primarily in mouse mammary tissue by 
litter removal at peak lactation (Strange et al.,1992; Richert et al.,2000). In our 
experiments, natural weaning, leaving pups till day 28 of lactation, was employed 
instead. This could have resulted in the increase in apoptosis at day 28 instead of 
earlier stages as previously reported (Quarrie et al.,1996).
At day 1 of a second lactation there was significantly more apoptosis 
occurring when compared to proliferation (Figure 3.11). Why this is so remains to 
be determined. However, Pitkow et al.(1972) did demonstrate that in rats a high 
percentage of alveolar cells are carried over to the next lactation. If applied to our 
experiment, it might explain why a higher rate of apoptosis is required to replace 
the spent alveolar cells from the previous lactation. However, the experimental 
design used by Pitkow et al.(1972) was different from ours. In their study animals 
were mated during the first parturition and hence had a short interval between 
lactations, whereas for ours, the animals were remated after the pups had been 
weaned. As our animals were allowed to involute, less alveolar cells might be 
carried over to the next lactation and hence there would be less need to replace
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spent alveolar cells. If the high apoptosis detected in our study was to replace 
spent alveolar cells, one would also expect to observe more proliferation to 
produce new alveolar cells. However, this was not observed in our study (Figure
3.11). The reason for the increase in apoptosis at day 1 of a second lactation 
remains to be determined.
The third objective of this chapter was to investigate the effect of previous 
reproductive histories on mammary epithelial cell proliferation and apoptosis. The 
effects of pregnancy and lactation on the incidence of breast cancer has been well 
documented (Ing et al.,1977; Newcomb,1997; Yang et al.,1999). Previously, a 
recent lactation has been shown to decrease oestrous-associated cell proliferation 
in the mouse mammary gland (Peris and Knight, 1997). The current objective was 
to determine whether this effect persists in the long-term. In addition, the effect of 
lactational history on apoptosis in mammary epithelial cells was studied. The 
effect of a previous lactation on mammary epithelial cell proliferation observed in 
this study was consistent with the earlier report (Peris and Knight, 1997). At 
24wks old, mice that had undergone lactation had lower oestrus-associated cell 
proliferation compared to the virgins (Figure 3.12). However, in contrast to the 
earlier data, a previous pregnancy without lactation had reduced cell proliferation 
(Figure 3.12). Although pregnancy and lactation appear to have similar effects, 
within-animal comparison of individual glands that had or had not lactated, 
revealed a reduction in cell proliferation only in ex-lactated glands (Figure 3.15). 
From these observations, we can see that proliferation of the mammary epithelial 
cells has been altered as a result of previous lactational history. At least part of
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this effect is exerted locally, since lactated glands showed the greatest reduction 
in mammary epithelial cell proliferation.
Before considering the apoptosis data it is necessary to reiterate a potential 
methodological problem with the data. When apoptosis within animals between 
groups were compared, we see that virgin and ex-pregnant mice exhibited higher 
apoptosis on the left gland than the right, which was not observed in ex-lactated 
mice (Figure 3.14). The difference in apoptosis between both glands could be a 
methodological consequence. When harvesting the mammary glands, the left 
gland was always collected and fixed before the right gland. This time-gap could 
have resulted in more apoptosis (or necrosis) occurring after the animal was 
sacrificed. However this does not account for the fact that the ex-lactators did not 
exhibit such differences between the glands.
Not withstanding this problem, apoptosis in mammary epithelial cells was 
more prevalent in virgin than in ex-pregnant mice (Figure 3.13). Ex-lactating 
mice had an intermediate value, not significantly different from virgins.
In the unilateral milking experiment (Figure 3.15), there was no significant 
difference in apoptosis between glands that had or had not lactated. It appears that 
the reduction in apoptosis caused by a previous pregnancy is subsequently 
reversed if the mouse lactates. Apoptosis, unlike proliferation, is subject to 
systemic rather than local influences since the unilateral milking showed that 
when one side of the gland has lactated, it reverse the reduction in apoptosis, 
observed in the ex-pregnant group, on the other gland that did not lactate.
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The studies in this chapter have provided novel insights in relation to 
breast cancer. From our proliferation and apoptosis studies, it is apparent that 
apoptosis in aged virgin mice was significantly reduced when compared to early 
stages. This is an interesting observation since breast cancers in women increase 
dramatically with age (Ries et al.,1996). These results suggest that this increase 
could be a consequence of decreased apoptosis. Furthermore, even though not 
statistically significant, a slight increase in proliferation is detected at this stage 
(Figure 3.9). With a lower rate of apoptosis (than usual) occurring, it means the 
probability of removing ‘cancer-causing’ mammary epithelial cells would be 
reduced This remains to be confirmed. The lactational history studies reveal a 
long-term beneficial effect of lactation. The decrease in proliferation in the face of 
maintained apoptosis produced by having lactated offers a potential mechanistic 
explanation for the protective effect of lactation against mammary tumours.
Since the number of mammary epithelial cells is a major determinant of 
milk production, an understanding of the cell kinetics in the mammary gland 
would also allow us to manage successful lactation more efficiently.
The wholemount analysis on mammary development was executed to 
determine the relationship between adipocytes and mammary epithelial cells. It is 
well established that the mammary gland has an obligate requirement for the fat 
pad. However, excessive obesity can compromise mammary development and 
lactation both in dairy species (Sejrsen and Purup,1997) and humans (Rasmussen 
et al.,2001). Indeed obese mice, ob/ob, have been suggested to have impaired 
mammary development (Knight and Sorensen,2001) and fail to lactate (Chehab et
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al.,1996). Nonetheless, caution still needs to be taken when associating 
observations obtained from heifers with those in ob/ob mice since different 
mechanism(s) might be involved in both situations. The observations of 
epithelial-adipocyte interactions made in the wholemount analyses form the 
starting point for a more detailed study, initially based around the ob/ob mouse. 
The interaction(s) between adipocytes and mammary epithelial cells could be 
investigated using in vivo models employing either nutritional or surgical 
manipulations so as to modify the adipocyte/epithelial ratio. This modification 
could be install at various stages of development to elucidate the potential 
interactions invovled.
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CHAPTER FOUR 
THE EFFECT OF STEROID HORMONES ON MAMMARY 
DEVELOPMENT IN LEPTIN-DEFICIENT, PRE-PUBERTAL MICE
4.1 INTRODUCTION
Interactions between the mammary fat pad and epithelial cells are 
obligatory for mammary development. The mammary gland requires a fat pad in 
which to develop. On the other hand, excessive obesity can compromise 
mammary development both in dairy species (Sejrsen and Purup,1997) and 
human (Rasmussen et al.,2001).
One of the potential mediators of adipocyte:epithelial interactions is leptin. 
In addition to its central role in the regulation of body energy homeostasis, leptin 
and its receptors have also been demonstrated to be expressed in the mammary 
gland (Smith-Kirwin et al.,1998; Aoki et al.,1999; Laud et al.,1999; Bonnet et 
al.,2002; Smith and Sheffield,2002). Mice lacking a functional leptin gene (ob/ob) 
are obese and sterile. Even though these mice exhibit normal early sexual 
development, they remain prepubertal and ovulation never occurs. This sterility 
has been associated with the insufficiency of hormones at the hypothalamic- 
pituitary level (Swerdloff et al.,1976). Chehab et al.(1996) demonstrated that 
fertility could be restored by administration of exogenous leptin. However, these 
mice still lack the capability to lactate upon parturition. Preliminary data showed 
that in young ob/ob mice, mammary development is depressed (Knight and 
Sorensen,2001). Ductal branching was restricted to the nipple region and so was
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greatly compromised when compared to lean counterparts in which an extensive 
network of ducts occupied much of the fat pad. Leptin might thus have an 
important stimulatory role in mammary development. However, since these mice 
fail to attain puberty, this compromised development in the ob/ob mammary gland 
could also be due to the deficiency of sexual hormones. Confirmation of this 
observation would allow us to determine whether leptin is obligatory for ductal 
growth.
The objectives of this chapter were first to confirm that mammary 
development was indeed impaired in the young ob/ob mouse and then to 
determine if this compromised development was a direct consequence of leptin 
deficiency. A cholesterol-based-slow-release pellet containing known 
mammogens, estrogen and progesterone in this instance, would be implanted into 
pre-pubertal lean and ob/ob mice. By determining whether TEBs in ob/ob mice 
are stimulated in the presence of estrogen and progesterone, we can establish 
whether lack of steroid mammogens or absence of leptin is responsible for the 
ob/ob phenotype.
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4.2 EXPERIMENTAL DESIGN
Female C57BL/601aHsd-Lepob (ob/ob) and -lean (lean) mice were purchased 
from Harlan (Harlan UK, 0X6 OTP U.K.), housed at a constant 17°C on a 12/12h 
light/dark cycle and fed a standard laboratory chow (CRMX:BS&S, EH7 6UL, 
U.K.). Four groups of mice were established. The first and second groups, 
comprising of 6 ob/ob mice each, were treated with cholesterol mixed with 
oestrogen and progesterone in the ratio 2002:1:1001 (OB-T) or cholesterol alone 
(OB-C) as a solid lOmg pellet implanted s.c. under Halothane anaesthesia on d22 
of life. The remaining two groups, 6 lean mice each (lean-T and lean-C), were 
treated identically. Fourteen days post-implantation, all mice were sacrificed and 
inguinal mammary glands were dissected. Wholemounts were prepared as 
described in section 2.2.3 except that an additional step of incubating the glands 
in acetone for 2 days before staining with carmine was included to remove as 
much fat as possible. Terminal end-buds (TEBs) were identified in the 
wholemounts and counted. The area of the fat pad and area occupied by epithelial 
component were also quantified by tracing the outline onto graph paper and 
counting the number of squares occupied.
4.3 STATISTICAL ANALYSIS
Results were interpreted by General Linear Model using Mintab (release 
11.21). Data for area occupied by ducts in the fat pad and ductal area were log 
transformed before being interpreted.
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4.4 RESULTS
Figures 4.1 & 4.2 illustrate wholemounts of the mammary gland, which in 
this instance are the inguinal, of a lean (A) and ob/ob (B) mice implanted with 
pellets containing either only cholesterol or estrogen, progesterone and 
cholesterol. Development of the ductal branching network in the ob/ob mice has 
been seriously compromised when compared to that in the lean mice. The 
branching network in the lean mice is infiltrating the fat pad while in the ob/ob 
mice, it is restricted to the area around the nipple. The control and steroid treated 
mice appear qualitatively similar
Visual inspection of the wholemounts suggested that the ob/ob mice had 
larger fat pads than the lean. This was quantified by tracing the outline of the fat 
pad onto graph paper and counting the number of squares. The data are in Figure 
4.3. Fat pads were, indeed, significantly larger in ob/ob mice, by 118% (P<
0.001). Treatment with oestrogen and progesterone, on the other hand, had no 
effect on fat pad size in either genotype.
The extent of the duct system differed greatly between ob/ob and lean 
mice (Figures 4.1 & 4.2, quantified in Figure 4.4). In obese mice the duct system 
occupied 2.8% of the fat pad, whereas in lean it occupied 49.3%. This difference 
was significant (P< 0.01). In addition, treatment with oestrogen and progesterone 
stimulated an increase in the percentage of ducts in the fat pad in both genotypes 
(P= 0.01). The extent of the increase did not differ between lean and ob/ob.
The difference in ductal percentage occupancy was partly a consequence 
of the enlarged fat pad of obese mice, but mostly due to an absolute difference in
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the size of the duct system (Figure 4.5). This was more than 7-fold greater in lean 
mice compared to ob/ob mice (P< 0.01) and was increased by 18.3% by treatment 
with oestrogen and progesterone (P< 0.05). The increments due to steroid 
treatment were 15.8 mm2 and 3.5 mm2 for lean and ob/ob, respectively. Although 
this suggests a greater response in lean, statistical analysis revealed no significant 
interaction between genotype and treatment, indicating that the treatment effect 
did not differ significantly between lean and ob/ob.
In addition to quantifying the area of fat pad and ducts occupying it, 
terminal end buds (TEBs) in the mammary gland were also scored (Figure 4.6). In 
lean mice, there was significantly more TEBs than in ob/ob mice (PO.OOl). 
Treatment with oestrogen and progesterone increased TEBs in both genotypes 
(P<0.05). There was no significant interaction between treatment and genotype 
(P>0.05).
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*Figure 4.1 Wholemounts of mammary gland from wildtype and ob/ob mice 
implanted with cholesterol pellets
Inguinal glands from both wildtype and ob/ob prebubertal mice were fixed, 
defatted and stained with carmine. Panel A shows the mammary gland derived 
from a wild type mouse while Panel B shows that of a ob/ob mousee. Bar = 2mm. 
The magnified areas showed that in the normal mouse the ductal system is well 
developed, but in the obese mouse the fat pad contains a limited number of ducts.
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BFigure 4.2 Wholemounts of mammary gland from wildtype and ob/ob mice 
implanted with pellets containing estrogen, progesterone and cholesterol.
Inguinal glands from both wildtype and ob/ob prebubertal mice were fixed, 
defatted and stained with carmine. Panel A shows the mammary gland derived 
from a wild type mouse while Panel B shows that of a ob/ob mouse. Bar = 2mm. 
The magnified areas showed that in the normal mouse the ductal system is well 
developed, but in the obese mouse the fat pad contains a limited number of ducts. 
In each case, the appearance of the gland is qualitatively similar to that of the 
untreated equivalent.
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Figure 4.3 Effect of genotype and steroid treatment on fat pad area
Lean and ob/ob mice were implanted with either cholesterol (control) or 
cholesterol mixed with oestrogen and progesterone in the ratio 2002:1:1001 
(treated). Mammary fat pad from both genotypes were quantified using standard 
grid square graph paper. Results are means ± SD for 6 animals and superscripts 
that differ are statistically significant (P< 0.01)
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Figure 4.4 Effect of genotype and steroid treatment on the area of the fat pad 
occupied by ducts
Lean and ob/ob mice were implanted with either cholesterol (control) or 
cholesterol mixed with oestrogen and progesterone in the ratio 2002:1:1001 
(treated). Area of fat pad occupied by ducts, from both lean and obese mice, was 
quantified using standard grid square graph paper. Results are means ± SD for 6 
animals and superscripts that differ are statistically significant. Lean vs ob/ob 
mice (P< 0.01) while control vs treated (P= 0.01)
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Figure 4.5 Effect of genotype and steroid treatment on ductal area
Wildtype and ob/ob mice were implanted with either cholesterol (control) or 
cholesterol mixed with oestrogen and progesterone in the ratio 2002:1:1001 
(treated). Ductal area from both lean and obese mice were quantified using 
standard grid square graph paper. Results are means ± SD for 6 animals and 
superscripts that differ are statistically significant. Lean vs ob/ob mice (P< 0.01) 
while control vs treated (P< 0.05)
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Figure 4.6 Effect of genotype and steroid treatment on the number of 
terminal end buds
Wildtype and ob/ob mice were implanted with either cholesterol (control) or 
cholesterol mixed with oestrogen and progesterone in the ratio 2002:1:1001 
(treated). After 2wks, wholemounts were prepared from these mice and the 
terminal end buds were quantified using histological counting. Results are means 
± SE for 6 animals. Superscripts that differ are statistically different. Lean vs 
ob/ob mice (P< 0.01) while control vs treated (P= 0.01)
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4.5 DISCUSSION
The first objective of this chapter was to establish if mammary 
development is compromised in the ob/ob mice. As shown in Figure 4.1 and 4.2, 
mammary development has definitely been impaired. In the lean mice, the ducts 
were observed to be infiltrating the fat pad whereas in the ob/ob, there was no 
such indication. The percentage of the fat pad occupied by ducts in the untreated 
ob/ob mice was 2.8% while the equivalent lean mice had 49.3% occupancy 
(Figure 4.4). Besides that, the size of the fat pad in the ob/ob mice was larger than 
lean mice [lean (44.78); ob/ob (102.47)] (Figure 4.3). Leptin when deficient 
results in over-feeding which leads to an increase in body fat store 
(Coleman, 1978). When leptin was administered in ob/ob mice, it resulted in 
weight loss which was restricted to adipose tissue (Halaas et al.,1995). Lean mice 
when given chronic infusions of leptin lost adipose mass in a dose-dependent 
manner (Halaas et al.,1997). Besides that it has also been shown that the lipid 
content and corresponding size of individual adipocytes correlates with the 
amount of ob gene expression (Maffei et al.,1995).
Both leptin and its receptor have been demonstrated to be expressed in 
mammary adipocytes and adipose tissue respectively (Lee et al.,1996; Bonnet et 
al.,2002). Thus the increase in size of fat pad in ob/ob mice could be due to the 
absence of possible autocrine control. Further studies are required to validate this 
claim.
Besides observing an increase in the size of fat pad, as mentioned earlier, 
the ob/ob mice also have reduced ductal growth in the mammary gland. This
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reduction in ductal growth could also be due to the direct consequence of leptin 
deficiency. Mammary epithelial cells have been shown to express the leptin 
receptor (Laud et al.,1999) and since mammary adipocytes produce leptin, 
potential paracrine signalling might be involved. The absence of leptin in ob/ob 
mice could have prevented cross-talk between the two cell types and hence a 
reduction in ductal growth. Recently, a paper showed that leptin is also produced 
in the bovine mammary epithelial cells (Smith and Sheffield,2002). This is an 
interesting observation since it indicates that leptin signalling in the mammary 
gland might be subjected to both autocrine and paracrine controls. This possibility 
seems even more likely when a recent paper demonstrated that leptin actually 
stimulated proliferation in the human breast cancer cell line T47-D (Laud et 
al.,2002). However, this observation remains contradictory as it did not agree with 
previous studies. Both Silva and VandeHaar (1999) and Purup and Sejrsen (2000) 
showed that leptin reduced the mitogenic effect of IGF-1 instead of stimulating 
proliferation in mammary epithelial cells. An important point to note is that, since 
proliferation was stimulated in a breast cancer cell line, it would be wise to 
determine if a similar effect is observed in normal human mammary epithelial 
cells when treated with leptin.
The second objective of this chapter was to determine if the mammary 
gland in ob/ob mice would respond to known mammogens since these mice are 
deficient of hormones at the hypothalamic-pituitary level (Swerdloff et al.,1976). 
The number of terminal end buds (TEBs) were quantified to assess the response 
to a combination of estrogen and progesterone. When the TEBs were quantified in
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both genotypes, there was significantly less TEBs in the ob/ob compared to the 
lean (Figure 4.6). When both lean and ob/ob mice have been treated with estrogen 
and progesterone, a significant increase in the number of TEBs was detected 
(Figure 4.6). Besides that, there was also an increase in the ductal area in both 
genotypes (Figures 4.4 & 4.5). From all these observations, we can see that the 
mammary gland is capable of responding to steroid-induced proliferation even in 
the absence of leptin. Since the mammary gland of ob/ob mice was capable of 
responding to steroid treatment, the mammary phenotype of these mice is at least 
partly a consequence of defective steroid secretion rather than solely a direct 
effect of leptin deficiency per se. However, since the individual variation was 
large (Figures 4.4-4.6) and the number of animals used in this experiment was 
small, the results obtained should be interpreted with caution.
Previous studies have shown that in heifers, increasing food intake during 
pre-pubertal stage results in a reduction in the ratio of ductular parenchyma:fatty 
stroma in the pubertal mammary gland (Sejrsen,1994). It has been suggested that 
the reduced mammary growth is due to a reduction in growth hormone (GH) 
(Weber et al.,1999). This is an interesting observation since ob/ob mice do have 
reduced GH (Sinha et al.,1975; Larson et al.,1976). Besides having reduced GH, 
prolactin was also reduced in these mice. GH and prolactin are known to be 
mitogenic in the mouse mammary gland so they might be responsible for the 
impaired development in the ob/ob mammary gland. To confirm this, further 
studies need to be conducted.
108
Besides local and endocrine factors, the microenvironment in the 
mammary gland of the ob/ob mice could have also contributed to the reduced 
ductal growth. The increase in the area of fat pad in ob/ob mice could have had an 
adverse effect on mammary development since transplantation experiments have 
shown that the ultimate number of epithelial cells within the mammary gland is 
dictated by the amount of adipose tissue in the mammary fat pad (Hoshino,1964). 
The fat pad could be releasing inhibitory factors to reduce normal ductal 
development. A potential inhibitory factor is TGF-p. It is secreted by the fat pad 
(Barcellos-Hoff,1996) and has been demonstrated to inhibit ductal elongation and 
branching in the mouse mammary gland (Daniel et al.,1989).
So far, we have seen that leptin is not directly involved in the pre-pubertal 
development of the mouse mammary gland since treatment with oestrogen and 
progesterone stimulated proliferation in the TEBs. In this instance, it is rather the 
lack of steroid hormones. However, as the effect of steroid implantation on 
mammary development in ob/ob mice were small and since the effect of leptin 
and its possible interaction with steroid hormones was not examined, a role for 
leptin at this stage could not be ruled out. Furthermore, since the mammary gland 
expresses leptin and its receptor, the involvement of leptin in mammary 
development is still possible. Besides that we have also discussed the possibility 
of other factors like GH, prolactin and TGF-P contributing to the reduced 
mammary development in these mice. Our studies on the role of leptin in 
mammary development even though still at its infancy, has nevertheless provided 
us insight for devising strategies for future work.
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CHAPTER FIVE
EFFECT OF LEPTIN ON PROLIFERATION AND DIFFERENTIATION 
OF MAMMARY EPITHELIAL CELLS
5.1 INTRODUCTION
Leptin when deficient in mice results in obesity, sterility and compromised 
development of the mammary gland (Coleman, 1973; Knight et al.,2002). In 
addition to having compromised development, these mice also fail to lactate upon 
parturition (Chehab et al.,1996). Leptin and its receptor are expressed in 
mammary tissue but this expression is down-regulated during lactation (Aoki et 
al.,1999; Laud et al.,1999). This has prompted the suggestion of a mammary 
developmental role for leptin. The in vivo experiments described in Chapter 4 
suggested that the failure of mammary development in ob/ob mice was at least 
partly due to the absence of steroid mammogenic stimuli, rather than lack of 
leptin. However, steroid treatment did not totally restore mammary growth, and so 
a role for leptin could not be ruled out.
The disadvantage of in vivo models is that one cannot easily distinguish 
between direct and indirect effects. Tissue culture circumvents this problem and 
allows for more rapid evaluation of putative bioactive factors. However, not all 
systems properly replicate the in vitro situation. The establishment of primary 
mammary epithelial cultures paved the way towards the elucidating of in vivo 
mammary function in vitro. Mouse (Barcellos-Hoff et al.,1989; Blatchford et 
al.,1995) and ovine (Wheeler et al.,1995; Finch et al.,1996) mammary epithelial
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cells, cultured in the presence of lactogenic hormones on Engelbreth-Holm- 
Swarm (EHS) matrix, formed alveoli-like structures (mammospheres) capable of 
synthesizing and secreting milk proteins. With a model such as this at hand, there 
is the possibility to confirm our in vivo observation on the role of leptin as a 
mammogen and also establish the possible involvement of leptin during lactation.
The aims of this chapter were
1. To determine the effect of leptin on proliferation of caprine mammary 
epithelial cells.
2. To determine the effect of leptin on differentiation of murine and caprine 
mammary epithelial cells.
I l l
5.2 EXPERIMENTAL DESIGN
5.2.1 Effect of leptin on proliferation of caprine mammary epithelial cells
Caprine mammary epithelial cells were recovered from liquid nitrogen and plated
at a density of 1 x 105/cm2 with a medium change each day. Cells were allowed 
24hr to attach before treatment. Ovine leptin, reconstituted in BSA (lOmg/ml), 
was added to individual culture wells at a final concentration of lOnM, 20nM and 
50nM. Triplicate wells were used for controls and each concentration of leptin 
tested. To assess proliferation, 3H-thymidine at 5 pCi/ml was added to the medium 
for 24hr at day 2, 3 and 4 of treatment. After 3H-thymidine incorporation, the 
medium from control and treated wells were first aspirated followed by harvesting 
of cells (Section 2.5.4). Cells were washed twice with PBS and then pelleted 
(13,000g, 1 min). The cell pellet was then resuspended in DNA assay buffer 
before being sonicated (Section 2.7). lOpl of homogenate was used to determine 
the incorporation of H-thymidine using liquid scintillation analyser while the 
remaining homogenate was used for DNA quantification.
5.2.2 Effect of leptin on differentiation of caprine mammary epithelial cells
Caprine mammary epithelial cells were recovered from liquid nitrogen and plated
c
at a density of 1 x 10 /cm with a medium change each day. The cells were 
allowed to proliferate until -90% confluent before transferring to the EHS matrix. 
When the cells had attached (after 24hr), they were treated with ovine leptin, at 
final concentrations of lOnM, 20nM or 50nM, for a period of 6 days. Triplicate 
wells were set up for both control and treated cells. At day 2, 4 and 6 of 
treatment, 35S-methionine (30pCi/ml) was added to the medium for 24hr. At days
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2, 4 & 6, medium, luminal extracts and cells were collected after incubating with 
35S-methionine. Protein synthesis and secretion were analyzed using TCA 
precipitation and a liquid scintillation analyser. Milk protein expression was 
assessed using western blotting for casein and p-lactoglobulin. Methods are 
described in detail in Chapter 2.
5.2.3 Effect of leptin on differentiation of mouse mammary epithelial cells
Mouse mammary epithelial cell clumps were differentiated on EHS matrix. After
attachment of the cell clumps, recombinant murine leptin prepared as 
recommended by manufacturer (R&D Systems, Abingdon, UK), at final 
concentrations of lOnM, 20nM or 50nM was added to the medium of treated 
wells. Triplicate wells were set up for both control and treated cells. Fresh 
medium with or without leptin was replenished daily. At day 2, 4 and 6 of 
treatment, 35S-methionine (30pCi/ml) was added to the medium for 24hr. 
Medium, luminal extracts and cells were collected after incubating with 35 S- 
methionine. Protein synthesis and secretion were measured using TCA 
precipitation and a liquid scintillation analyser. Milk protein secretion was 
analysed using SDS-PAGE and autoradiography for casein.
5.2.4 Effect of ovine leptin on differentiation of mouse mammary epithelial 
cells
Mouse mammary epithelial cell clumps were differentiated on EHS matrix. After 
attachment of the cell clumps, ovine leptin (50nM final concentration), was added 
to the medium of treated wells. Triplicate wells were set up for both control and 
treated cells. Fresh medium with or without leptin was replenished daily. At day
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2, 4 and 6 of treatment, 35S-methionine (30pCi/ml) was added to medium for 
24hr. Medium, luminal extracts and cells were collected after incubating with 
35S-methionine. Protein synthesis and secretion were analyzed using TCA 
precipitation and a liquid scintillation analyser. Milk protein expression was 
assessed using SDS-PAGE and autoradiography for casein.
5.3 Statistical analysis
Results were first normalised by log transformation before being compared by 
ANOVA using Genstat Genstat 5 (Release 4.1, Lawes Agricultural Trust, 
Rothamsted Experimental Station, Herts, UK). For all experiments, ANOVA was 
fitted with concentration of leptin and days of treatment as fixed factors and 
experiment number as a random factor.
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5.4 RESULTS
5.4.1 Biological activity of ovine leptin
The ovine leptin used was a gift from Professor Arieh Gertler (The Hebrew
University of Jerusalem, Israel). The bioactivity of ovine leptin was confirmed by 
its administration into an ob/ob mouse (Fig 5.1). Bovine serum albumin (BSA), 
used to reconstitute ovine leptin, was injected into a second ob/ob mouse as a 
control. The mice were injected twice daily either with ovine leptin (24pg) or 
BSA (1.5mg). The mouse treated with ovine leptin displayed rapid weight loss 
(~lg/day) whereas the mouse treated with BSA did not show any weight loss and
on the contrary gained weight from days 2 - 3 of treatment.
1 2 3
D a y s  o f  t r e a t m  e n t
Figure 5.1 Administration of ovine leptin to OB mice
Ob mice were injected twice daily with ovine leptin (24 pg) and BSA 
(1.5mg) as a control for a period of 3 days. The weight of these mice was 
recorded daily.
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5.4.2 The effect of ovine leptin on proliferation of caprine mammary
epithelial cells
To determine the mitogenic effect of leptin, caprine mammary epithelial 
cells were plated at equal cell density onto culture wells (triplicates) and treated 
with ovine leptin. The concentrations of ovine leptin tested were 10, 20 and 
50nM. Data presented in Figure 5.2 are the mean of 3 experiments, each with 
cells from a different goat, and analysis was carried out with experiment numbers 
as a random factor. There was a significant day effect (P< 0.01) on the 
proliferation of these cells in both control and treated wells, proliferation 
increasing with days of culture (Figure 5.2). However, ovine leptin, at all 
concentrations tested, did not stimulate or inhibit proliferation in caprine 
mammary epithelial cells since incorporation of 3H-thymidine did not differ 
significantly between control and treated cells (P> 0.05, Figure 5.2).
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Figure 5.2 Effect of leptin on proliferation of caprine mammary epithelial 
cells
Caprine mammary epithelial cells were plated at a density of lx  10 /cm and 
treated with ovine leptin for 4 days. Cell proliferation was determined using 3H- 
thymidine incorporation. Results shown are means ± SE for 3 experiments.
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5.4.3 Characterization of caprine mammosphere cultures
Before leptin’s effects on differentiation of caprine mammary epithelial 
cells could be assessed, a method had to be developed for culture of caprine 
mammospheres. In our laboratory, we have demonstrated that when murine and 
ovine mammary epithelial cells were cultured on EHS matrix, in the presence of 
lactogenic hormones (insulin, hydrocortisone, prolactin), they were capable of 
differentiation. Furthermore, instead of forming a monolayer, they formed clumps 
called ‘mammospheres’.
Figure 5.3 demonstrates caprine mammary epithelial cells forming 
mammospheres. Using phase-contrast microscopy (Figure 5.3B) and also DAPI 
nuclear-staining (Figure 5.3C), these mammospheres were shown to contain a 
luminal area which is morphologically reminiscent of the alveoli in vivo.
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Figure 5.3 Caprine mammary epithelial cells forming mammospheres
Caprine mammary epithelial cells when cultured on EHS in the presence of 
lactogenic hormones formed ‘mammospheres’. All three panels represented 
mammospheres from Day 2 o f culture. Panels A & B were taken using a phase- 
contrast microscope under the magnification o f X I0 and X40 respectively. Bar = 
5pm. Panel C is a 4pm thick cryo-section o f a mammosphere stained with the 
nuclear stain, DAPI, and photographed using brightfield microscope under X40 
magnification. Bar = 20pm.
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Besides forming structures resembling a lactating mammary gland, the 
luminal cells were demonstrated to be actively secreting proteins. Figure 5.4 
shows luminal secretion of proteins in the caprine mammospheres. Data presented 
are the means of 3 experiments. Protein secretion in the lumen increased with 
days of culture.
2.5 n
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Figure 5.4 Luminal secretion of proteins in the caprine mammospheres
Caprine mammospheres were cultured on EHS matrix, in the presence of 
lactogenic hormones, for 7 days. S-methionine incorporation was used to 
determine luminal secretion of protein. Luminal proteins were harvested using 
EGTA. Results are means ± SE of 3 experiments.
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To determine if milk proteins were secreted by the caprine 
mammospheres, western blotting for casein and p-lactoglobulin was carried out. 
Figure 5.5 shows that both milk proteins were being secreted by the caprine 
mammospheres. Casein secretion was highest at day 7 of culture while P- 
lactoglobulin secretion reached its maximum at day 5 of culture.
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Figure 5.5 Total secretion of casein and beta-lactoglobulin in caprine 
mammospheres
Culture medium and luminal extracts were first resolved on a 12% Bis-Tris gel on 
an equal DNA basis followed by western blotting with primary antibodies for 
bovine casein and p-lactoglobulin. Both proteins were quantified using a 
densitometer.
casein
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5.4.4 The effect of ovine leptin on differentiation of caprine mammospheres
To evaluate the role of ovine leptin on the differentiation of caprine
mammospheres, protein synthesis and secretion, in particular casein and p- 
lactoglobulin secretion, were analyzed. Data presented in this section are the 
means of 3 experiments, each with cells from a different goat, and analysis was 
carried out with number of experiment as a random factor.
Figure 5.6 shows the effect of ovine leptin on total (luminal & 
basolateral) secretion of proteins by caprine mammospheres. Protein secretion in 
the mammospheres increased with days of culture in both control and treated 
mammospheres (PO.Ol). However, treatment with ovine leptin, at all 
concentrations tested, of caprine mammospheres did not have any significant 
effect on secretion of proteins (P> 0.05).
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Figure 5.6 Total protein secretion by caprine mammospheres treated with 
ovine leptin
Total protein secretion (luminal & basolateral) by caprine mammospheres treated 
with ovine leptin was determined by S-methionine incorporation. Luminal 
secretion was harvested using EGTA while basolateral secretion was obtained 
from conditioned medium. Results are means ± SE of 3 experiments.
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Since leptin did not affect protein secretion in the caprine mammospheres, the 
next step was to determine if protein synthesis in these mammospheres was 
affected by leptin. Data presented is the means of 3 experiments, and analysis was 
carried out with number of experiment as a random factor.
Figure 5.7 shows protein synthesis in caprine mammospheres when treated with 
ovine leptin. Protein synthesis in both control and treated mammospheres were 
constant with days of culture. At all concentrations of leptin tested, there was no 
significant effect on protein synthesis (P> 0.05).
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Figure 5.7 Effect of ovine leptin on protein synthesis by caprine 
mammospheres
Caprine mammospheres were treated with ovine leptin for 6 days. Intracellular 
protein synthesis on days 2, 4 and 6 of treatment as determined b y 35S-methionine 
incorporation. Cell pellets derived from mammospheres were first sonicated and 
then analysed using a liquid scintillation analyser. Results are means ± SE of 3 
experiments.
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In addition to measuring protein synthesis and secretion in the caprine 
mammospheres, the secretion of milk proteins was also studied. The two milk 
proteins analyzed in this experiment were casein and P-lactoglobulin (BLG). 
Figure 5.8 shows total secretion of casein in caprine mammospheres when treated 
with ovine leptin. The secretion of casein in these mammospheres increased with 
days of culture (P< 0.01). At day 6 of treatment, casein secretion had increased 
remarkably when compared to day 2 and 4 of treatment. Despite this, treatment of 
ovine leptin, did not stimulate nor inhibit casein secretion by caprine 
mammospheres (P> 0.05).
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Figure 5.8 Total casein secretion of caprine mammospheres treated with 
ovine leptin
Culture medium and luminal extracts from days 2 ,4 , and 6 of treatment were first 
resolved on a 12% Bis-Tris gel on an equal DNA basis, followed by western 
blotting with primary antibodies for bovine casein. Casein was quantified using a 
densitometer. Total casein (luminal and basolateral) secretion shown is the mean 
± SE of 3 experiments.
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After examining the effect of leptin on the secretion of casein, the 
secretion of whey protein, BLG, was analysed. Figure 5.9 shows total secretion of 
BLG when the caprine mammospheres were treated with ovine leptin. Treatment 
of leptin did not affect total secretion of BLG by caprine mammospheres (P> 
0.05).
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Figure 5.9 Total BLG secretion by caprine mammospheres treated 
with ovine leptin
Culture medium and luminal extracts from days 2, 4 and 6 of treatment 
were first resolved on a 12% Bis-Tris gel on an equal DNA basis followed 
by western blotting with primary antibodies for bovine p-lactoglobulin 
(BLG). BLG was quantified using a densitometer. Total BLG (luminal and 
basolateral) secretion shown is the mean ± SE of 3 experiments.
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5.4.5 The effect of murine leptin on differentiation of mouse
mammospheres
To evaluate the role of murine leptin on the differentiation of mouse 
mammospheres, they were treated with recombinant mouse leptin for a period of 
6 days. As previously, protein synthesis, secretion and milk protein expression 
were examined to determine the effect of leptin on differentiation. Data presented 
in this section are the means of 3 experiments and analysis was carried out with 
experiment number as a random factor.
Figure 5.10 shows total protein secretion by the mouse mammospheres 
when treated with mouse leptin. Leptin at 50nM seemed to have an inhibitory 
effect on protein secretion on days 4 and 6 of treatment but this was not 
statistically significant (P> 0.05).
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Figure 5.10 Total protein secretion by mouse mammospheres treated with 
mouse leptin
Total protein secretion (luminal & basolateral) by mouse mammospheres treated 
with mouse leptin was determined by 35S-methionine incorporation. Luminal 
secretion was harvested using EGTA while basolateral secretion was obtained 
from conditioned medium. Results are means ± SE of 3 experiments.
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Protein synthesis was measured in these mammospheres (Figure 5.11). 
There was no significant difference between treated and controls (P> 0.05).
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Figure 5.11 Intracellular protein synthesis by mouse mammospheres treated 
with mouse leptin
Intracellular protein synthesis in mouse mammospheres treated with mouse leptin
^ c
was determined by S-methionine incorporation. Cell pellets derived from 
mammospheres were first sonicated and then analysed using a liquid scintillation 
analyser. Results are means ± SE of 3 experiments.
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When casein secretion was analyzed, leptin again had no significant effect 
on total secretion of casein (Figure 5.12). Casein secretion in both control and 
treated wells were highest on day 4 when compared with days 2 and 6 of 
treatment (P< 0.01). As previously, casein secretion seems to be inhibited, 
especially at days 4 and 6 of treatment, when the mouse mammospheres were 
treated with 50nM leptin. However, this was not statistically significant when 
compared to the controls (P> 0.05). All the results from the mouse 
mammospheres showed that leptin did not affect differentiation of mouse 
mammospheres.
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Figure 5.12 Total secretion of casein by mouse mammosphere treated with 
mouse leptin
Culture medium and luminal extracts from days 2, 4 and 6 of treatment were first 
resolved on a 12% Bis-Tris gel on an equal DNA basis followed by 
autoradiography. Total casein secretion (luminal and basolateral) was quantified 
using a densitometer. Results are means ± SE of 3 experiments.
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5.4.6 The effect of ovine leptin on differentiation of mouse mammospheres
Data presented in this section are the means of 4 experiments and analysis was
carried out with experiment number as a random factor. When mouse 
mammospheres were treated with ovine leptin (50nM), total secretion of proteins 
(Figure 5.13), on day 6 of treatment, was marginally higher than the controls (P= 
0.069). In addition there was also a day effect on treated mammospheres 
(P<0.05). However, when data were transformed, by taking a natural logarithm, 
this significant effect of leptin on total protein secretion was no longer observed
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Figure 5.13 Total secretion of proteins by mouse mammospheres treated with 
ovine leptin
Total protein secretion (luminal & basolateral) by mouse mammospheres treated 
with ovine leptin for 6 days was determined by 35S-methionine incorporation. 
Results are means ± SE of 4 experiments.
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Whether this supposingly increased secretion in protein as a consequence of 
leptin treatment was due to an increase in intracellular protein synthesis was 
addressed in Figure 5.14. Leptin treatment did not stimulate more protein 
synthesis in the mouse mammospheres when compared with the controls (P> 
0.05).
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Figure 5.14 Intracellular protein synthesis by mouse mammospheres treated 
with ovine leptin
Intracellular protein synthesis in mouse mammospheres treated with ovine leptin 
was determined by 35S-methionine incorporation. Cell pellets derived from 
mammospheres were first sonicated and then analysed using a liquid scintillation 
analyser. Results are means ± SE of 4 experiments.
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The next stage of analysis was to determine whether treatment with ovine leptin 
affected casein secretion in the mouse mammospheres. Figure 5.15 shows total 
secretion of casein by mouse mammospheres when treated with ovine leptin. 
Treatment with leptin seems to be stimulating secretion of casein especially from 
day 4 to 6 of treatment, however this was not statistically significant (P>0.05). In 
this experiment, ovine leptin did not have any significant effect on the synthesis 
and secretion of proteins, and differentiation of the mouse mammospheres. 
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Figure 5.15 Total secretion of casein by mouse mammospheres treated 
with ovine leptin
Culture medium and luminal extracts were first resolved on a 12% Bis- 
Tris gel on an equal DNA basis followed by autoradiography. Total casein 
secretion was quantified using a densitometer. Results are means ± SE of 
4 experiments
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5.5 DISCUSSION
Leptin, in addition to its role as a satiety factor has been shown to 
stimulate proliferation in various cell types. It has been shown to stimulate 
proliferation of the mouse embryonic cell line, C3H10T1/2, as a consequence of 
increased mitogen-activated protein kinase activity (Takahashi et al.,1997). Other 
studies have also shown that leptin is capable of stimulating proliferation of 
hemopoietic cells (Gainsford et al.,1996) through activation of janus kinase 2 
(Ghilardi and Skoda, 1997). Previously, Laud et al.(1999) suggested a mitogenic 
role for leptin in the ovine mammary gland, since the highest expression of its 
receptor was detected at the stage where initiation of mammary epithelial cell 
proliferation occurs during pregnancy. From our current studies, we demonstrated 
that ovine leptin does not stimulate or inhibit proliferation in caprine mammary 
epithelial cells (Figure 5.2). The recombinant ovine leptin used is biologically 
active (Figure 5.1) thus the lack of effect observed here can be considered 
genuine. However, as late pregnant goat mammary epithelial cells were used in 
our study and highest expression of leptin receptor in the ovine mammary gland 
was detected in early pregnancy (Laud et al.,1999), it could have had an impact 
on the response of mammary epithelial cells to leptin. Nevertheless, our 
observation generally agrees with previous studies. Leptin, on its own, has been 
shown not to have any effect on proliferation of primary bovine mammary 
epithelial cells cultured on collagen (Purup and Sejrsen,2000), and bovine 
mammary epithelial cell line, MAC-T (Silva and VandeHaar,1999). Conversely, 
these studies showed that leptin, in the presence of IGF-1, tend to be inhibitory to
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mammary epithelial cell proliferation, suggesting an antagonistic effect on IGF-1 
mediated signalling. Contradictory to all these observations, a recent paper 
showed that leptin actually stimulates proliferation in the breast cancer cell line 
T47-D (Laud et al.,2002). The applicability of this observation to normal 
mammary epithelial cells is debatable, since breast cancer cells are ‘transformed’ 
so they might exhibit properties or responses that might not be observed in normal 
cells.
Differentiation of mammary epithelial cells in culture has been established 
in both rodents and ruminants. It has been shown that when mammary epithelial 
cells are cultured on EHS matrix, in the presence of lactogenic hormones, they 
form structures called mammospheres which resemble the alveoli in the lactating 
gland (Hurley et al.,1994; Wilde et al.,1995; Finch et al.,1996). Besides being 
structurally similar, these mammospheres exhibited polarized epithelial 
ultrastructure to allow vectorial secretion of milk proteins. Here, mammosphere 
culture was successfully applied to caprine mammary epithelial cells. 
Mammosphere formation and milk protein synthesis and secretion were achieved 
(Figures 5.3-5.5).
In this study, leptin has been demonstrated not to have any significant 
effect on the differentiation of mouse and caprine mammary epithelial cells 
(Section 5.4.4- 5.4.6). In both species, protein synthesis, secretion and the 
expression and secretion of milk proteins were not significantly affected by leptin 
treatment. However, this study did show that when mouse mammospheres were 
treated with ovine leptin, total secretion of proteins showed a marginal significant
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increase. When the raw data were normalised by log transformation, this effect 
was removed.
It is perhaps not surprising to see this effect of ovine leptin on mouse 
mammospheres, even though not significant, since ovine leptin has been shown to 
have 84% sequence identity to mouse leptin (Dyer et al.,1997), indicating that the 
leptin is highly conserved between species. Furthermore, various studies have also 
demonstrated that using leptin from a different species does activate leptin 
signalling. Ovine leptin was able to stimulate DNA synthesis in cells expressing 
the human leptin receptor (Gertler et al.,1998). Human leptin, when injected into 
ob/ob mice was able to induce weight loss and restore fertilty (Chehab et al.,1996; 
Mounzih et al.,1998). This was further supported by our own studies which also 
showed that ovine leptin was able to induce weight loss in ob/ob mice (Figure 
5.1).
Expression of leptin (mouse and ovine) and its receptor (ovine) has been 
detected in the mammary gland (Aoki et al.,1999; Laud et al.,1999; Bonnet et 
al.,2002) and this expression is down-regulated during lactation. It has been 
shown in rats that levels of serum leptin are suppressed during lactation due to the 
metabolic drain of milk production (Pickavance et al., 1998; Brogan et al.,1999). 
This suppression of serum leptin has been suggested to be due to an increase in 
energy demand and hence the need to increase appetite. On the other hand, 
prolactin has been demonstrated to reduce leptin expression in the mouse 
mammary epithelial cell line, COMMA-ID (Aoki et al.,1999) and insulin-induced 
leptin secretion in mouse adipocytes (Ling and Billig,2001). This is interesting as
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it might suggest an antagonistic role for prolactin since we know that expression 
of leptin and its receptor is lowest during lactation. On the other hand, this might 
not be the case since in sheep, short-days and melatonin treatment which 
decreases prolactin, did not effect plasma leptin or adipose tissue leptin mRNA 
(reviewed in Chilliard et al., 2001). What needs to be established is whether 
prolactin reduces the expression of leptin receptor in the mammary gland.
The ovine mammary gland expresses the short-form receptor, which has 
been localized to the mammary alveolar epithelial cells (Laud et al.,1999). 
However, whether mouse and caprine mammary epithelial cells and 
mammospheres express the leptin receptor in vitro remains to be determined. This 
lack of effect by leptin observed in the present study could be due to the absence 
of leptin receptor.
If cultured mammary epithelial cells express the leptin receptor, it would 
be worthwhile determining whether it is the long or short form receptor since the 
two isoforms have different signalling capabilities. The short form receptor, 
unlike the long form, lacks the intracellular domain that is responsible for leptin 
signalling in the hypothalamus. On the other hand, short form receptors have been 
shown to mediate leptin-dependent tyrosine phosphorylation of JAK2 and IRS-1 
and activation of MAPK activity in transient transfection models (Bjorbaek et 
al.,1997).
The short form receptors of leptin have also been shown to be capable of 
modulating signalling in the long form receptor (White et al.,1997). This indicates 
a potential regulatory role for the short form receptor. If mammary epithelial cells
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expresses the short-form receptor in vitro, this could also explain why a local 
effect was not observed since the short form receptor might be acting as a 
feedback mechanism that eventually relates a signal to the long-form receptors in 
the hypothalamus to instruct. This remains to be determined
A very recent study showed that leptin expression changes in cellular 
location during different stages of mammary gland development (Bonnet et 
al.,2002). During early pregnancy, leptin was located in adipocytes and just 
before parturition, it was localised to the mammary epithelial cells. During 
lactation, expression of leptin was detected in the myoepithelial cells. This 
observation provided evidence that leptin could act as a paracrine factor rather 
than autocrine in the mammary gland.
From all the observations we have obtained so far, leptin clearly has no 
effect on proliferation of caprine and differentiation of both caprine and mouse 
mammary epithelial cells in vitro. Nonetheless, leptin might still have a role in 
the mammary gland. Since supraphysiological concentrations of leptin were 
employed in this study, it is possible that the putative physiological effect could 
have been masked. In addition, there is the possibilty that the exogenous leptin 
could have been subjected to significant proteolysis in vitro. Besides that, various 
studies have demonstrated the lipolytic effect of leptin on adipocytes (Fruhbeck et 
al.,1997; Fruhbeck et al.,1998; Kawaji et al.,2001; Marti et al.,2001). Even though 
this effect has not been demonstrated in the sheep mammary gland (Newby et al., 
2001), it still raises the possibility that leptin might exert its effect by acting as a
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controller of adiposity and since leptin expression in the gland varies with stage of 
development, paracrine rather than autocrine signalling might be involved.
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CHAPTER SIX
GENERAL DISCUSSION
Mammary gland development and function is a complex process involving 
autocrine, paracrine and endocrine control. The gland, at birth, consists of a 
rudimentary branching network, which upon puberty, infiltrates the fat pad. 
Previously, the fat pad has been regarded as an inert matrix solely acting as a 
support for the growth of the mammary epithelial branching networks. However, 
this has been shown not to be the case; instead the fat pad is obligatory for normal 
mammary development (Neville et al.,1998; Hovey et al.,1999). One way the fat 
pad exerts its effect is by acting as a site for the synthesis and secretion of 
biologically active substances. Some of the substances secreted by the fat pad 
include IGF-1, TGF-P, FGF, Wnt gene family members, ECM components and 
leptin, the cytokine involved in satiety (Maffei et al.,1995; Barcellos-Hoff,1996; 
Hovey et al.,1999). From earlier results and discussion, it is apparent that adipose- 
epithelial interactions play a pivotal role in mammary development and function. 
Hence the elucidation of the reasons for this association and the understanding of 
how paracrine factors contribute to normal development, would provide a better 
understanding of the control of mammary development and prevention of breast 
cancers.
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6.1 Mammary epithelial cell apoptosis and proliferation in the mouse
mammary gland during different stages of development
The initial objective of this thesis was to examine mammary development 
in relation to mammary epithelial cell proliferation and apoptosis occurring in the 
gland during different stages of development. Since the number of mammary 
epithelial cells is a major determinant of milk production and a shift from the 
equilibrium between these two processes can lead to lesions in the mammary 
gland, a better understanding of both proliferation and apoptosis is beneficial. The 
first experiment comprised a wholemount analysis of murine mammary gland 
development during different stages of development with the aim of providing a 
detailed picture of mammary gland morphogenesis and to measure the relative 
proportions and distributions of adipose and alveolar tissue. The former study 
generated observations that were consistent with those of Richert et al.(2000) and 
proved to be an efficient and reliable protocol for assessing development of the 
gland as a whole.
In studying proliferation and apoptosis of mammary epithelial cells during 
the different stages of development, several intriguing observations were noted 
even though the absolute values of the ratio of proliferation/apoptosis were not 
related to the true rate of mammary development in the experimental animals. 
Proliferation in the virgin mice, as expected, was consistent regardless of age. In 
contrast, apoptosis tended initially to increase with age but this increase was no 
longer observed as the animal aged further. Rather, there was a marked 
subsequent decrease in apoptosis later in life, which is intriguing since it has been
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shown in women that incidence of breast cancer increases with age. The reduction 
of apoptosis may lead to the preservation of genetically aberrant cells hence 
favouring neoplastic development. This is one area of research that deserves 
further study. Proliferation of mammary epithelial cells during pregnancy and 
lactation generated expected findings, with highest proliferation occurring at mid 
pregnancy.
The next part of this study was to examine the effect of lactational history 
on apoptosis and estrous-associated proliferation of mammary epithelial cells in 
aged mice. Again, the study generated some significant observations. The first 
observation showed clear evidence of decreased mammary apoptosis in later life 
in mice that had undergone pregnancies, when compared to virgins, and this 
decrease was partly reversed by lactation. Secondly, lactational history was also 
demonstrated to have a long-term effect on oestrous-associated proliferation of 
mammary epithelial cells. Cell proliferation was significantly lower in mice that 
had been pregnant than it was in virgin, but the lowest rate was recorded in mice 
that had been pregnant and had also lactated. Beneficial effects of pregnancy and 
lactation on the incidence of breast cancer have been established (Ing et al.,1977; 
Newcomb,1997; Yang et al.,1999). Based on our observations, we could postulate 
that this ‘protective’ effect of lactational history is modulated through the control 
of mammary epithelial cell apoptosis and oestrous-associated proliferation. It is 
known that in some breast cancers, the increase in cell proliferation (Christov et 
al.,1994) and also a decrease in apoptosis (Hassan and Walker, 1998) are 
contributing factors to the lesions. In rats, the neoplastic transformation of
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mammary epithelial cells in TEBs have also been associated with decreased 
apoptotic cell death (Shilkaitis et al.,2000).
6.2 Role of leptin in mammary gland
Obesity is becoming more prevalent, especially in western countries, and 
there is increasing evidence linking obesity to lactation failure in humans as well 
(Donath and Amir,2000; Rasmussen et al.,2001). It is well known that obesity 
affects milk yield in both rats and cows. Overfeeding of dairy cows leads to the 
development of the fat cow syndrome resulting in lactation failure 
(Morrow, 1975). When pre-pubertal heifers were fed on high planes of nutrition, 
they had less secretory tissue in their mammary gland (Sejrsen et al.,1982) 
resulting in reduced milk yield potential (Sejrsen and Purup,1997; Sejrsen et 
al.,2000). In rats, over-nutrition also produced similar observations 
(Rasmussen, 1998).
The second objective of the study was to examine the role of leptin in 
mammary gland development and function, since both leptin and its receptor are 
expressed in the mammary gland (Aoki et al.,1999; Laud et al.,1999; Bonnet et 
al.,2002). Studies so far have indicated highest expression of leptin in virgin and 
pregnant animals (Aoki et al.,1999; Laud et al.,1999). Furthermore, prepubertal 
mice deficient in leptin have also been demonstrated to have impaired mammary 
development (Knight et al.,2002). For these reasons we decided to determine if 
leptin has a mammogenic role in the mammary gland.
Using both in vitro and in vivo models, data were obtained to indicate that 
leptin does not have such a role. Steroid implantation in prepubertal ob/ob mice
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concluded that the impaired development of the mammary gland was not a direct 
effect of leptin but a consequence of the inability to attain puberty since 
proliferation of TEBs was stimulated in the absence of leptin. Furthermore, when 
mid-late pregnant caprine mammary epithelial cells were exposed to leptin in 
vitro, proliferation was neither stimulated nor inhibited.
Since the expression of leptin and its receptor in the mammary gland is 
down-regulated during lactation (Aoki et al.,1999; Laud et al.,1999) and mice 
deficient in leptin fail to lactate in the first instance (Chehab et al.,1996), we 
decided to examine if leptin influences lactation in relation to differentiation of 
mammary epithelial cells. Leptin at all concentrations tested did not affect the 
differentiation of either murine or caprine mammary epithelial cells in vitro. We 
concluded that leptin is not directly responsible for the failure to lactate in ob/ob 
mice.
This failure to lactate in ob/ob mice is more likely a consequence of 
impaired development in the mammary gland induced by factors other than leptin 
deficiency. Moreover, it was evident that this impairment could be overcome 
since in subsequent pregnancies, this failure to lactate was partially removed in 
some of the ob/ob mice (Chehab et al.,1996). Besides that, our current study also 
demonstrated that after the initial failure of lactation (first 3 days) by ob/ob mice, 
the pups which were litter-swapped for the first 3 days, gradually gained weight 
as milk secretion was fully established. By day 10 of lactation weight gain was 
indistinguishable from the lean mice (Knight et al.,2002). To verify the ‘slower- 
developmenf hypothesis, wholemounts and wax-embedded sections of the
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mammary gland from ob/ob mice, undergoing their first and subsequent rounds of 
pregnancy and lactation, could be prepared and compared. If a delayed 
development was detected during first pregnancy, that would explain why these 
mice were unable to lactate in the first instance.
6.3 Conclusion
The studies described in this thesis were to address two key points in 
relation to mammary gland development and function. Studies on mammary 
epithelial cell proliferation and apoptosis showed that the two processes varied 
during different stages of development, especially between different reproductive 
histories. This has provided a novel approach towards improved understanding 
and prevention of pathological mammary development and breast cancer.
The second objective was to evaluate the role of leptin in the mammary 
gland. Leptin per se is very unlikely to have a functional role in mammogenesis 
and lactogenesis. The impaired mammary development and failure to lactate 
displayed by leptin-deficient ob/ob mice is rather the consequence of a lack of 
steroid mammogenic hormones. Thus, while the fat pad plays an important role in 
mammary gland development, leptin is not primarily involved.
Nonetheless, recent studies have shown increasing evidence linking 
obesity and breast cancer (Stoll,2000; La-Guardia and Giammanco,2001; 
McCann,2001; Wolk et al.,2001). Our studies when taken together provided us an 
insight towards forming strategies for future investigations to elucidate the 
relationship between adipose and mammary tissues.
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Future studies could employ primary cultures, as used in the present study, 
to determine the contribution(s) of the fat pad towards mammary gland 
development, function and breast cancer. For instance, factors known to be 
secreted by the fat pad could be introduced into mammary epithelial cells in vitro. 
However, this method is effective only if the factor(s) have a direct effect on 
mammary epithelial cells.
As previous studies have suggested that some growth factors might exert 
their effects in the mammary gland through cross-talk, conditioned medium 
derived from pre-adipocytes and adipocytes, either of mammary origin or from 
other fat depots, could also be introduced into primary mammary epithelial cell 
cultures to study putative paracrine interactions. Medium from pre-adipocyte and 
mature adipocyte would allow us to determine if such interactions are 
developmentally regulated. Media that affected epithelial cell proliferation or 
differentiation could then be analysed for growth factors or other active 
constituents, which could subsequently be identified through standard techniques 
such as chromatography. In addition to these recommendations, another 
promising area of research is to establish primary cultures of adipocytes derived 
from obese humans/animals. Conditioned medium would facilitate the elucidation 
of unknown factors that might only be secreted in obese but not lean counterparts.
Putative paracrine interactions between mammary adipocytes and 
epithelial cells could also be studied using co-cultures. Models as such allows one 
to mimick the tissue’s organisation in vivo and also determine whether 
synthesis/secretion of respective factors is subject to paracrine influences.
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Mammary epithelial cells derived from different stages of development could be 
co-cultured with pre-adipocytes/adipocytes to determine if such interactions are 
developmentally regulated. In addition, adipocytes from fat depots other than 
those of mammary origin could also be co-cultured with mammary epithelial cells 
to establish whether interactions as such are mammary-specific. Mammary 
epithelial cells and adipocytes, when separated by a basement membrane like 
EHS matrix, would also allow one to determine the influence of basement 
membrane on paracrine signalling as binding of growth factors and other 
molecules may modify the epithelial response to adipocyte-generated signals.
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